CLK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A2RRP1 | S473 | Sugiyama | NBAS NAG | APKRSRLETRAGEEDEGEEDsDsDyEISAKARYFGYIKQGL |
| A2RRP1 | S475 | Sugiyama | NBAS NAG | KRSRLETRAGEEDEGEEDsDsDyEISAKARYFGYIKQGLYL |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15047 | S470 | Sugiyama | SETD1A KIAA0339 KMT2F SET1 SET1A | sPEREEVRtsPRPAsPARsGsPAPEttNESVPFAQHSSLDS |
| O15061 | S1044 | Sugiyama | SYNM DMN KIAA0353 SYN | ASEMEKAVESVVREsLsRQRsPAPGsPDEEGGAEAPAAGIR |
| O60927 | S77 | Sugiyama | PPP1R11 HCGV TCTE5 | ssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHRKG |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O95394 | S64 | Sugiyama | PGM3 AGM1 | LLAVLRSKQTKSTIGVMVtAsHNPEEDNGVKLVDPLGEMLA |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00519 | T735 | SIGNOR|EPSD|PSP | ABL1 ABL JTK7 | RsCsAsCVPHGAKDTEWRSVtLPRDLQStGRQFDSstFGGH |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S114 | Sugiyama | ALPP PLAP | DRFPYVALSKTYNVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P06744 | T109 | Sugiyama | GPI | KINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLDKM |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07951 | S271 | Sugiyama | TPM2 TMSB | KtIDDLEDEVyAQKMKYKAIsEELDNALNDItsL_______ |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08621 | S226 | GPS6|PSP | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | VNIRHSGRDDtsRyDERPGPsPLPHRDRDRDRERERRERSR |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09923 | S111 | Sugiyama | ALPI | DRFPYLALSKTYNVDRQVPDsAATATAYLCGVKANFQTIGL |
| P10696 | S111 | Sugiyama | ALPG ALPPL ALPPL2 | DRFPYVALSKTYSVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P16949 | S38 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | QAFELILsPRsKEsVPEFPLsPPKKKDLsLEEIQKKLEAAE |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P18031 | S242 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | PTPN1 PTP1B | SGTFCLADTCLLLMDKRKDPssVDIKKVLLEMRKFRMGLIQ |
| P18031 | S243 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | PTPN1 PTP1B | GTFCLADTCLLLMDKRKDPssVDIKKVLLEMRKFRMGLIQT |
| P18031 | S50 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PTPN1 PTP1B | FPCRVAKLPKNKNRNRyRDVsPFDHSRIKLHQEDNDyINAs |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18754 | S11 | Sugiyama | RCC1 CHC1 | __________MsPKRIAKRRsPPADAIPKsKKVKVsHRsHs |
| P18858 | T183 | Sugiyama | LIG1 | sLTEAEVAtEKEGEDGDQPttPPKPLKTSKAEtPtEsVsEP |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27348 | T30 | Sugiyama | YWHAQ | AKLAEQAERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKN |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T87 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKR |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P42166 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsND |
| P42167 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSND |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46937 | T114 | Sugiyama | YAP1 YAP65 | sFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQL |
| P49759 | S140 | Sugiyama | CLK1 CLK | HHSTSHRRSHGKSHRRKRtRsVEDDEEGHLICQSGDVLSAR |
| P49759 | S337 | Sugiyama | CLK1 CLK | INPDIKVVDFGsATyDDEHHstLVstRHyRAPEVILALGWS |
| P49759 | S341 | Sugiyama | CLK1 CLK | IKVVDFGsATyDDEHHstLVstRHyRAPEVILALGWSQPCD |
| P49759 | T315 | Sugiyama | CLK1 CLK | LFVQSDYTEAYNPKIKRDERtLINPDIKVVDFGsATyDDEH |
| P49759 | T338 | Sugiyama | CLK1 CLK | NPDIKVVDFGsATyDDEHHstLVstRHyRAPEVILALGWSQ |
| P49759 | T342 | Sugiyama | CLK1 CLK | KVVDFGsATyDDEHHstLVstRHyRAPEVILALGWSQPCDV |
| P49759 | Y345 | Sugiyama | CLK1 CLK | DFGsATyDDEHHstLVstRHyRAPEVILALGWSQPCDVWSI |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P52742 | S308 | Sugiyama | ZNF135 ZNF61 ZNF78L1 | HQRTHTGEKPYECSECGKSFsFRSSFSQHERTHTGEKPYEC |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P55081 | S132 | Sugiyama | MFAP1 | VVGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMM |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62750 | T42 | Sugiyama | RPL23A | LKAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPR |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| Q00839 | S267 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KRPREDHGRGyFEyIEENKysRAKsPQPPVEEEDEHFDDtV |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q12968 | S161 | Sugiyama | NFATC3 NFAT4 | LERPSRDHLyLPLEPSYRESsLsPsPASSISSRSWFsDAss |
| Q13112 | S410 | Sugiyama | CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 | LNMRtPDtAKKTKsQtHRGssPGPRPVEGtPASRtQDPssP |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13263 | S138 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | PVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCCTSCED |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13285 | S203 | PSP | NR5A1 AD4BP FTZF1 SF1 | YLYPAFPGRAIKSEYPEPYAsPPQPGLPYGYPEPFSGGPNV |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q92974 | S956 | Sugiyama | ARHGEF2 KIAA0651 LFP40 | RLQDssDPDtGsEEEGssRLsPPHsPRDFtRMQDIPEEtEs |
| Q96G46 | S272 | Sugiyama | DUS3L | EGAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVR |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96GM8 | S420 | Sugiyama | TOE1 | KNDLEMGIKAARPEIADRATsEVPGsQAsPNPVPGDGLHRA |
| Q96I25 | S202 | SIGNOR|EPSD|PSP | RBM17 SPF45 | VEKDKELPRDFPyEEDSRPRsQsSKAAIPPPVyEEQDRPRs |
| Q96I25 | S204 | SIGNOR|EPSD|PSP | RBM17 SPF45 | KDKELPRDFPyEEDSRPRsQsSKAAIPPPVyEEQDRPRsPt |
| Q96I25 | S222 | SIGNOR|EPSD|PSP | RBM17 SPF45 | sQsSKAAIPPPVyEEQDRPRsPtGPsNsFLANMGGTVAHKI |
| Q96I25 | S266 | SIGNOR|EPSD|PSP | RBM17 SPF45 | YGFREGQGLGKHEQGLSTALsVEKTSKRGGKIIVGDATEKD |
| Q96I25 | S288 | SIGNOR|EPSD|PSP | RBM17 SPF45 | EKTSKRGGKIIVGDATEKDAsKKsDsNPLTEILKCPTKVVL |
| Q96I25 | S291 | SIGNOR|EPSD|PSP | RBM17 SPF45 | SKRGGKIIVGDATEKDAsKKsDsNPLTEILKCPTKVVLLRN |
| Q96I25 | S48 | SIGNOR|EPSD|PSP | RBM17 SPF45 | sQLQVKKAALTQAKSQRTKQsTVLAPVIDLKRGGssDDRQI |
| Q96I25 | S62 | SIGNOR|EPSD|PSP | RBM17 SPF45 | SQRTKQsTVLAPVIDLKRGGssDDRQIVDtPPHVAAGLKDP |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96QK1 | S786 | Sugiyama | VPS35 MEM3 TCCCTA00141 | INKHFHNtLEHLRLRREsPEsEGPIyEGLIL__________ |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BRS2 | S507 | Sugiyama | RIOK1 RIO1 | ENQVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDP |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BX95 | S112 | Sugiyama | SGPP1 SPP1 | GLAAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLF |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H7D7 | S123 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | SSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLNQT |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9HAZ1 | S335 | Sugiyama | CLK4 | KNTDIKVVDFGsATyDDEHHstLVstRHyRAPEVILALGWS |
| Q9HAZ1 | S339 | Sugiyama | CLK4 | IKVVDFGsATyDDEHHstLVstRHyRAPEVILALGWSQPCD |
| Q9HAZ1 | T336 | Sugiyama | CLK4 | NTDIKVVDFGsATyDDEHHstLVstRHyRAPEVILALGWSQ |
| Q9HAZ1 | T340 | Sugiyama | CLK4 | KVVDFGsATyDDEHHstLVstRHyRAPEVILALGWSQPCDV |
| Q9HAZ1 | Y343 | Sugiyama | CLK4 | DFGsATyDDEHHstLVstRHyRAPEVILALGWSQPCDVWSI |
| Q9HDC5 | S413 | Sugiyama | JPH1 JP1 | QAALAARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVD |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NR19 | S30 | Sugiyama | ACSS2 ACAS2 | sGsGSRGQEEAGAGGRARsWsPPPEVsRSAHVPSLQRYREL |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NYF8 | S320 | Sugiyama | BCLAF1 BTF KIAA0164 | sPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKRF |
| Q9P2T1 | S37 | Sugiyama | GMPR2 | LRPKRSTLKsRsEVDLTRSFsFRNSKQTYSGVPIIAANMDT |
| Q9UJ70 | S76 | Sugiyama | NAGK | AKRKAGVDPLVPLRsLGLsLsGGDQEDAGRILIEELRDRFP |
| Q9UJY1 | S24 | Sugiyama | HSPB8 CRYAC E2IG1 HSP22 PP1629 | GQMPFSCHYPsRLRRDPFRDsPLsSRLLDDGFGMDPFPDDL |
| Q9UPR0 | T584 | Sugiyama | PLCL2 KIAA1092 PLCE2 | KILIKAKKLsSNCSGVEGDVtDEDEGAEMSQRMGKENMEQP |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | S2694 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQSSs |
| Q9UQ35 | S876 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tsPQANEQsVtPQRRsCFEssPDPELKsRtPsRHsCsGssP |
| Q9Y2W1 | S805 | Sugiyama | THRAP3 BCLAF2 TRAP150 | QSSHSYKAEEYTEEtEEREEstTGFDKSRLGTKDFVGPSER |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.853104e-10 | 9.545 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.151275e-09 | 8.667 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.056092e-09 | 8.515 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.491981e-09 | 8.188 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.273833e-07 | 6.278 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 7.652132e-07 | 6.116 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.660622e-06 | 5.575 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.623855e-06 | 5.581 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.334133e-06 | 5.363 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.210512e-06 | 5.283 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.699645e-06 | 5.174 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.693299e-06 | 5.114 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.409550e-05 | 4.851 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.623577e-05 | 4.790 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.555730e-05 | 4.592 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.489125e-05 | 4.604 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.452264e-05 | 4.610 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.720221e-05 | 4.565 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.601065e-05 | 4.252 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.819049e-05 | 4.235 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.279667e-05 | 4.202 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.103559e-04 | 3.957 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.422702e-04 | 3.847 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.507296e-04 | 3.822 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.670505e-04 | 3.777 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.670505e-04 | 3.777 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.121576e-04 | 3.673 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.225051e-04 | 3.491 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.352048e-04 | 3.475 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.456946e-04 | 3.461 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.766693e-04 | 3.424 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.500428e-04 | 3.347 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.724285e-04 | 3.326 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.355572e-04 | 3.197 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 8.225788e-04 | 3.085 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.045786e-04 | 3.094 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.406091e-04 | 3.075 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.969403e-04 | 3.047 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.122528e-03 | 2.950 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.107756e-03 | 2.956 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.206615e-03 | 2.918 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.371716e-03 | 2.863 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.336993e-03 | 2.874 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.467480e-03 | 2.833 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.443463e-03 | 2.841 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.687540e-03 | 2.773 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.704598e-03 | 2.768 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.880676e-03 | 2.726 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.022112e-03 | 2.694 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.202318e-03 | 2.657 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.202318e-03 | 2.657 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.327914e-03 | 2.633 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.406290e-03 | 2.619 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.406290e-03 | 2.619 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.832598e-03 | 2.548 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.831081e-03 | 2.548 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.626440e-03 | 2.581 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.832598e-03 | 2.548 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.997412e-03 | 2.523 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.184212e-03 | 2.497 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.318635e-03 | 2.479 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.468982e-03 | 2.460 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.532952e-03 | 2.452 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.773509e-03 | 2.423 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.916769e-03 | 2.407 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.186482e-03 | 2.378 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.205898e-03 | 2.376 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.339862e-03 | 2.363 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.851874e-03 | 2.314 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.899307e-03 | 2.310 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.932164e-03 | 2.307 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.035334e-03 | 2.298 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.035334e-03 | 2.298 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.513487e-03 | 2.259 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.856319e-03 | 2.232 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 5.969449e-03 | 2.224 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.433419e-03 | 2.192 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.899241e-03 | 2.161 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.907214e-03 | 2.161 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.141923e-03 | 2.146 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.213279e-03 | 2.142 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.718827e-03 | 2.112 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.718827e-03 | 2.112 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.718827e-03 | 2.112 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.176220e-03 | 2.087 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.002263e-03 | 2.097 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 8.176220e-03 | 2.087 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.126990e-03 | 2.090 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.249385e-03 | 2.084 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.607436e-03 | 2.065 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 9.577199e-03 | 2.019 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.009055e-02 | 1.996 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.009055e-02 | 1.996 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.009055e-02 | 1.996 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.066388e-02 | 1.972 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.127492e-02 | 1.948 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.153415e-02 | 1.938 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.185577e-02 | 1.926 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.214137e-02 | 1.916 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.233783e-02 | 1.909 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.272842e-02 | 1.895 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.272842e-02 | 1.895 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.272842e-02 | 1.895 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.407700e-02 | 1.851 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.407700e-02 | 1.851 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.485047e-02 | 1.828 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.571297e-02 | 1.804 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.571297e-02 | 1.804 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.571297e-02 | 1.804 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.671767e-02 | 1.777 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.696910e-02 | 1.770 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.696261e-02 | 1.771 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.642859e-02 | 1.784 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.737143e-02 | 1.760 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.834175e-02 | 1.737 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.943252e-02 | 1.711 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.037090e-02 | 1.691 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.943252e-02 | 1.711 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.016613e-02 | 1.695 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.007191e-02 | 1.697 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.098568e-02 | 1.678 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.113625e-02 | 1.675 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.138935e-02 | 1.670 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.183497e-02 | 1.661 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.183497e-02 | 1.661 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.260931e-02 | 1.646 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.307005e-02 | 1.637 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.381868e-02 | 1.623 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.659309e-02 | 1.575 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.562764e-02 | 1.591 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.533721e-02 | 1.596 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.438437e-02 | 1.613 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.638259e-02 | 1.579 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.765299e-02 | 1.558 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.889713e-02 | 1.539 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.913090e-02 | 1.536 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.913090e-02 | 1.536 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.092583e-02 | 1.510 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.002561e-02 | 1.523 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.230248e-02 | 1.491 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.230248e-02 | 1.491 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.116424e-02 | 1.506 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.116424e-02 | 1.506 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.092583e-02 | 1.510 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.201931e-02 | 1.495 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.952791e-02 | 1.530 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.419493e-02 | 1.466 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.456143e-02 | 1.461 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.508531e-02 | 1.455 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.508531e-02 | 1.455 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.508531e-02 | 1.455 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.587241e-02 | 1.445 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.593666e-02 | 1.444 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.996428e-02 | 1.398 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.150772e-02 | 1.382 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 4.214249e-02 | 1.375 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.228818e-02 | 1.374 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.282778e-02 | 1.368 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.301689e-02 | 1.366 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.628448e-02 | 1.335 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.691239e-02 | 1.329 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.448778e-02 | 1.352 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.882679e-02 | 1.311 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 4.963921e-02 | 1.304 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 4.963921e-02 | 1.304 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.985381e-02 | 1.302 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.118542e-02 | 1.291 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.308565e-02 | 1.275 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.308565e-02 | 1.275 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.308565e-02 | 1.275 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.373025e-02 | 1.270 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.497927e-02 | 1.260 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.546518e-02 | 1.256 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.546518e-02 | 1.256 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.546518e-02 | 1.256 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.546518e-02 | 1.256 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.702269e-02 | 1.244 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.702269e-02 | 1.244 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.440968e-02 | 1.191 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.776953e-02 | 1.238 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.094619e-02 | 1.215 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.990351e-02 | 1.223 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.771270e-02 | 1.239 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.440968e-02 | 1.191 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.704618e-02 | 1.174 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.821148e-02 | 1.166 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.821148e-02 | 1.166 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.821148e-02 | 1.166 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.821148e-02 | 1.166 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.023574e-02 | 1.153 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.023574e-02 | 1.153 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.023574e-02 | 1.153 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.180425e-02 | 1.087 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.180425e-02 | 1.087 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.180425e-02 | 1.087 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.180425e-02 | 1.087 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.180425e-02 | 1.087 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 8.180425e-02 | 1.087 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.180425e-02 | 1.087 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.180425e-02 | 1.087 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.698008e-02 | 1.114 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.773714e-02 | 1.109 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.943391e-02 | 1.100 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 7.793821e-02 | 1.108 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.906899e-02 | 1.102 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.793821e-02 | 1.108 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 8.180425e-02 | 1.087 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.878274e-02 | 1.104 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.793821e-02 | 1.108 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 7.265816e-02 | 1.139 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 8.064852e-02 | 1.093 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.187322e-02 | 1.087 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.500223e-02 | 1.071 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.500223e-02 | 1.071 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.500223e-02 | 1.071 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.198386e-02 | 1.036 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.198386e-02 | 1.036 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.198386e-02 | 1.036 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 9.198386e-02 | 1.036 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 9.077173e-02 | 1.042 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.843047e-02 | 1.053 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 9.929473e-02 | 1.003 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.989397e-02 | 1.046 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.056032e-02 | 1.043 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.322712e-02 | 1.030 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.843047e-02 | 1.053 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.493942e-02 | 1.023 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.493942e-02 | 1.023 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.357517e-02 | 1.029 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.739174e-02 | 1.059 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.843047e-02 | 1.053 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 8.993336e-02 | 1.046 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.968020e-02 | 1.001 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.968020e-02 | 1.001 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.968020e-02 | 1.001 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.112987e-01 | 0.954 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.112987e-01 | 0.954 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.112987e-01 | 0.954 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.112987e-01 | 0.954 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.112987e-01 | 0.954 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.112987e-01 | 0.954 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.112987e-01 | 0.954 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.112987e-01 | 0.954 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.112987e-01 | 0.954 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.112987e-01 | 0.954 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.112987e-01 | 0.954 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 1.185831e-01 | 0.926 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.185831e-01 | 0.926 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 1.185831e-01 | 0.926 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.161299e-01 | 0.935 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.161299e-01 | 0.935 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.161299e-01 | 0.935 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.161299e-01 | 0.935 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.057448e-01 | 0.976 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.036173e-01 | 0.985 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.036173e-01 | 0.985 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.116737e-01 | 0.952 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.116737e-01 | 0.952 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.092384e-01 | 0.962 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.092384e-01 | 0.962 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.092384e-01 | 0.962 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.021269e-01 | 0.991 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.021269e-01 | 0.991 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.115022e-01 | 0.953 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.047642e-01 | 0.980 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 1.057448e-01 | 0.976 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.190230e-01 | 0.924 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.003608e-01 | 0.998 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.035399e-01 | 0.985 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.036173e-01 | 0.985 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.021269e-01 | 0.991 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.124667e-01 | 0.949 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.161299e-01 | 0.935 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.036173e-01 | 0.985 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.197173e-01 | 0.922 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.141790e-01 | 0.942 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.115022e-01 | 0.953 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.208347e-01 | 0.918 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.213417e-01 | 0.916 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.218124e-01 | 0.914 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.218463e-01 | 0.914 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.219300e-01 | 0.914 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.231333e-01 | 0.910 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.231333e-01 | 0.910 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.231333e-01 | 0.910 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.231333e-01 | 0.910 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.231333e-01 | 0.910 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.231333e-01 | 0.910 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.231333e-01 | 0.910 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.279877e-01 | 0.893 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.316869e-01 | 0.880 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.102158e-01 | 0.677 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.102158e-01 | 0.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.102158e-01 | 0.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.102158e-01 | 0.677 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.102158e-01 | 0.677 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.102158e-01 | 0.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.102158e-01 | 0.677 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.585516e-01 | 0.800 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.585516e-01 | 0.800 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.585516e-01 | 0.800 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.585516e-01 | 0.800 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.585516e-01 | 0.800 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.585516e-01 | 0.800 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.981280e-01 | 0.526 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.981280e-01 | 0.526 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.981280e-01 | 0.526 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.981280e-01 | 0.526 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.981280e-01 | 0.526 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.981280e-01 | 0.526 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.981280e-01 | 0.526 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.981280e-01 | 0.526 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.981280e-01 | 0.526 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.981280e-01 | 0.526 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 2.981280e-01 | 0.526 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.981280e-01 | 0.526 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.981280e-01 | 0.526 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.981280e-01 | 0.526 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.981280e-01 | 0.526 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.981280e-01 | 0.526 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.981280e-01 | 0.526 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.981280e-01 | 0.526 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.981280e-01 | 0.526 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.005448e-01 | 0.698 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.005448e-01 | 0.698 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.005448e-01 | 0.698 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.005448e-01 | 0.698 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.005448e-01 | 0.698 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.005448e-01 | 0.698 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.423478e-01 | 0.847 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.423478e-01 | 0.847 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.423478e-01 | 0.847 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.423478e-01 | 0.847 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 1.423478e-01 | 0.847 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.423478e-01 | 0.847 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.436177e-01 | 0.613 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.436177e-01 | 0.613 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 2.436177e-01 | 0.613 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.436177e-01 | 0.613 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.436177e-01 | 0.613 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.762592e-01 | 0.425 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.762592e-01 | 0.425 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.762592e-01 | 0.425 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.762592e-01 | 0.425 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.438364e-01 | 0.842 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.438364e-01 | 0.842 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.996557e-01 | 0.700 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.996557e-01 | 0.700 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.996557e-01 | 0.700 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.657901e-01 | 0.780 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.870102e-01 | 0.542 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.870102e-01 | 0.542 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.390118e-01 | 0.857 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.390118e-01 | 0.857 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.300881e-01 | 0.638 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 2.300881e-01 | 0.638 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.300881e-01 | 0.638 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 2.300881e-01 | 0.638 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.300881e-01 | 0.638 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.300881e-01 | 0.638 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.300881e-01 | 0.638 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.888427e-01 | 0.724 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.571677e-01 | 0.804 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.762321e-01 | 0.754 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.128374e-01 | 0.672 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.128374e-01 | 0.672 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.128374e-01 | 0.672 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.612926e-01 | 0.583 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.301179e-01 | 0.481 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.301179e-01 | 0.481 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.301179e-01 | 0.481 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.301179e-01 | 0.481 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.301179e-01 | 0.481 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.301179e-01 | 0.481 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 3.301179e-01 | 0.481 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 3.301179e-01 | 0.481 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.456970e-01 | 0.351 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.456970e-01 | 0.351 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.456970e-01 | 0.351 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.456970e-01 | 0.351 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.456970e-01 | 0.351 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.456970e-01 | 0.351 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.378105e-01 | 0.861 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.961173e-01 | 0.707 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.376163e-01 | 0.624 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.929847e-01 | 0.533 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.929847e-01 | 0.533 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.929847e-01 | 0.533 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.929847e-01 | 0.533 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.929847e-01 | 0.533 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.929847e-01 | 0.533 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.983092e-01 | 0.703 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.630225e-01 | 0.580 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 3.724669e-01 | 0.429 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.724669e-01 | 0.429 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.422370e-01 | 0.847 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.165331e-01 | 0.664 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.165331e-01 | 0.664 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.978552e-01 | 0.704 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.352970e-01 | 0.628 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.930740e-01 | 0.714 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.545358e-01 | 0.594 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.545358e-01 | 0.594 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.545358e-01 | 0.594 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.136922e-01 | 0.383 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.136922e-01 | 0.383 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.136922e-01 | 0.383 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.074083e-01 | 0.295 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.074083e-01 | 0.295 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.074083e-01 | 0.295 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.074083e-01 | 0.295 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.074083e-01 | 0.295 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.074083e-01 | 0.295 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.074083e-01 | 0.295 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.459196e-01 | 0.836 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.484702e-01 | 0.605 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.860207e-01 | 0.730 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 3.885150e-01 | 0.411 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.885150e-01 | 0.411 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.273921e-01 | 0.485 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.144377e-01 | 0.502 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.503811e-01 | 0.455 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.489123e-01 | 0.604 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.349129e-01 | 0.475 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.198151e-01 | 0.377 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.210302e-01 | 0.493 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.210302e-01 | 0.493 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.967823e-01 | 0.528 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.555339e-01 | 0.449 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.586000e-01 | 0.445 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.586000e-01 | 0.445 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.586000e-01 | 0.445 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.586000e-01 | 0.445 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.965053e-01 | 0.402 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.505598e-01 | 0.346 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.505598e-01 | 0.346 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.505598e-01 | 0.346 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.505598e-01 | 0.346 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.917486e-01 | 0.308 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 4.917486e-01 | 0.308 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.622523e-01 | 0.250 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.622523e-01 | 0.250 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.965144e-01 | 0.402 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.806153e-01 | 0.318 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.720200e-01 | 0.326 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.282425e-01 | 0.277 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.282425e-01 | 0.277 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.282425e-01 | 0.277 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.282425e-01 | 0.277 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.282425e-01 | 0.277 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.344097e-01 | 0.362 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.098696e-01 | 0.293 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.482640e-01 | 0.348 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.394161e-01 | 0.357 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.382315e-01 | 0.269 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.629136e-01 | 0.250 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.629136e-01 | 0.250 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.629136e-01 | 0.250 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.109930e-01 | 0.214 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.109930e-01 | 0.214 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.109930e-01 | 0.214 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.109930e-01 | 0.214 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.109930e-01 | 0.214 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.109930e-01 | 0.214 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.109930e-01 | 0.214 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.456722e-01 | 0.263 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.656286e-01 | 0.247 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.656286e-01 | 0.247 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.656286e-01 | 0.247 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.623520e-01 | 0.250 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.669239e-01 | 0.246 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.920053e-01 | 0.228 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 5.751921e-01 | 0.240 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.916753e-01 | 0.228 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.916753e-01 | 0.228 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.916753e-01 | 0.228 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.916753e-01 | 0.228 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.862692e-01 | 0.232 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.862692e-01 | 0.232 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.123482e-01 | 0.213 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.123482e-01 | 0.213 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.123482e-01 | 0.213 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.266340e-01 | 0.203 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.543093e-01 | 0.184 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.543093e-01 | 0.184 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.543093e-01 | 0.184 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.543093e-01 | 0.184 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.543093e-01 | 0.184 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.292527e-01 | 0.201 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.415500e-01 | 0.193 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.415500e-01 | 0.193 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.415500e-01 | 0.193 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.498830e-01 | 0.187 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.556825e-01 | 0.183 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.556825e-01 | 0.183 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.556825e-01 | 0.183 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.556825e-01 | 0.183 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.556825e-01 | 0.183 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.556825e-01 | 0.183 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.646766e-01 | 0.177 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.646766e-01 | 0.177 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.646766e-01 | 0.177 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.318935e-01 | 0.635 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.134725e-01 | 0.671 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.110559e-01 | 0.507 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.408929e-01 | 0.851 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.265561e-01 | 0.279 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.417844e-01 | 0.848 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.734463e-01 | 0.428 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.920053e-01 | 0.228 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.920053e-01 | 0.228 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.952040e-01 | 0.530 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.806153e-01 | 0.318 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.806153e-01 | 0.318 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.589892e-01 | 0.338 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.339215e-01 | 0.631 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.498830e-01 | 0.187 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.498830e-01 | 0.187 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 3.965144e-01 | 0.402 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.597653e-01 | 0.585 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.661644e-01 | 0.575 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.957152e-01 | 0.225 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.344248e-01 | 0.476 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.711851e-01 | 0.243 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.632854e-01 | 0.178 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.427776e-01 | 0.265 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.423001e-01 | 0.354 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.144020e-01 | 0.212 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.996557e-01 | 0.700 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.415053e-01 | 0.467 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.790082e-01 | 0.320 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.016206e-01 | 0.521 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.510411e-01 | 0.600 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.098696e-01 | 0.293 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.265561e-01 | 0.279 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.860207e-01 | 0.730 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.376163e-01 | 0.624 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.806887e-01 | 0.743 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.929847e-01 | 0.533 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.666303e-01 | 0.778 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.629136e-01 | 0.250 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.483062e-01 | 0.829 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.985649e-01 | 0.702 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.862692e-01 | 0.232 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.389857e-01 | 0.857 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.244075e-01 | 0.205 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.761204e-01 | 0.239 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.444408e-01 | 0.612 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.376163e-01 | 0.624 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 3.249044e-01 | 0.488 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.424138e-01 | 0.846 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.136922e-01 | 0.383 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.535192e-01 | 0.343 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.282425e-01 | 0.277 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.172173e-01 | 0.286 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.136155e-01 | 0.212 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.748754e-01 | 0.171 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.844852e-01 | 0.734 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.457513e-01 | 0.351 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.600520e-01 | 0.180 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.504424e-01 | 0.346 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.005448e-01 | 0.698 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.436177e-01 | 0.613 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.301179e-01 | 0.481 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.535192e-01 | 0.343 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.535192e-01 | 0.343 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.917486e-01 | 0.308 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.917486e-01 | 0.308 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.109930e-01 | 0.214 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.857839e-01 | 0.314 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.545358e-01 | 0.594 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.589961e-01 | 0.445 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.123482e-01 | 0.213 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.556825e-01 | 0.183 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.741685e-01 | 0.759 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.585516e-01 | 0.800 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.005448e-01 | 0.698 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.929847e-01 | 0.533 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.724669e-01 | 0.429 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.249044e-01 | 0.488 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.965053e-01 | 0.402 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.098696e-01 | 0.293 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.790082e-01 | 0.320 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.382315e-01 | 0.269 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 6.109930e-01 | 0.214 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.725709e-01 | 0.242 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.556825e-01 | 0.183 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.556825e-01 | 0.183 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.636334e-01 | 0.334 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.745416e-01 | 0.426 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.082988e-01 | 0.216 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.230027e-01 | 0.281 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.273921e-01 | 0.485 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.996557e-01 | 0.700 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.661644e-01 | 0.575 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.679556e-01 | 0.434 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.107186e-01 | 0.386 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.107186e-01 | 0.386 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.107186e-01 | 0.386 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.107186e-01 | 0.386 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.821478e-01 | 0.740 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.154862e-01 | 0.381 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.154862e-01 | 0.381 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.436807e-01 | 0.843 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.600846e-01 | 0.337 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.268960e-01 | 0.644 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.449782e-01 | 0.462 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.648963e-01 | 0.333 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.561911e-01 | 0.448 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.772768e-01 | 0.751 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.005448e-01 | 0.698 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.436177e-01 | 0.613 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 2.870102e-01 | 0.542 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.128374e-01 | 0.672 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.612926e-01 | 0.583 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.568173e-01 | 0.448 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.136922e-01 | 0.383 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.622523e-01 | 0.250 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.872078e-01 | 0.312 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.944485e-01 | 0.226 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.543093e-01 | 0.184 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.556825e-01 | 0.183 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.227193e-01 | 0.491 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.583388e-01 | 0.800 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.458449e-01 | 0.836 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.083970e-01 | 0.511 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.198151e-01 | 0.377 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.390118e-01 | 0.857 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.249044e-01 | 0.488 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.311554e-01 | 0.636 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.205445e-01 | 0.376 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.080391e-01 | 0.511 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.629136e-01 | 0.250 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.996557e-01 | 0.700 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.470071e-01 | 0.460 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.484702e-01 | 0.605 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.617308e-01 | 0.791 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.175136e-01 | 0.379 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.456970e-01 | 0.351 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.074083e-01 | 0.295 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.622523e-01 | 0.250 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.375467e-01 | 0.472 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.109930e-01 | 0.214 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.556825e-01 | 0.183 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.556825e-01 | 0.183 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.603806e-01 | 0.443 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.603806e-01 | 0.443 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.473434e-01 | 0.459 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.610245e-01 | 0.180 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.889029e-01 | 0.539 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.484702e-01 | 0.605 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.842303e-01 | 0.546 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.870102e-01 | 0.542 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.108826e-01 | 0.676 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.382315e-01 | 0.269 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.543093e-01 | 0.184 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.939300e-01 | 0.712 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.107186e-01 | 0.386 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.136922e-01 | 0.383 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.771545e-01 | 0.423 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.380406e-01 | 0.623 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.154862e-01 | 0.381 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.591864e-01 | 0.586 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.813893e-01 | 0.741 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.928483e-01 | 0.533 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.833027e-01 | 0.548 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.669239e-01 | 0.246 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.216884e-01 | 0.283 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.816773e-01 | 0.550 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.205092e-01 | 0.657 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.586811e-01 | 0.181 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.775374e-01 | 0.423 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.382775e-01 | 0.269 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.102158e-01 | 0.677 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.423478e-01 | 0.847 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.703011e-01 | 0.769 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.703011e-01 | 0.769 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.436177e-01 | 0.613 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.762592e-01 | 0.425 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.762592e-01 | 0.425 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.300881e-01 | 0.638 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.128374e-01 | 0.672 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.612926e-01 | 0.583 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.612926e-01 | 0.583 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.301179e-01 | 0.481 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.456970e-01 | 0.351 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.929847e-01 | 0.533 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.724669e-01 | 0.429 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.379795e-01 | 0.623 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.249044e-01 | 0.488 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.136922e-01 | 0.383 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.136922e-01 | 0.383 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.535192e-01 | 0.343 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.198151e-01 | 0.377 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.198151e-01 | 0.377 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.555339e-01 | 0.449 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.622523e-01 | 0.250 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.622523e-01 | 0.250 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.969666e-01 | 0.401 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.471133e-01 | 0.460 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.942168e-01 | 0.404 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.262521e-01 | 0.645 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.344097e-01 | 0.362 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.098696e-01 | 0.293 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.382315e-01 | 0.269 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.109930e-01 | 0.214 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 6.109930e-01 | 0.214 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.109930e-01 | 0.214 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.504424e-01 | 0.346 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.690157e-01 | 0.245 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.920053e-01 | 0.228 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.828286e-01 | 0.417 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.223647e-01 | 0.282 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.375467e-01 | 0.472 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.375467e-01 | 0.472 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.691791e-01 | 0.433 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.215277e-01 | 0.207 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.748754e-01 | 0.171 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.379795e-01 | 0.623 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.535192e-01 | 0.343 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.957152e-01 | 0.225 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.173213e-01 | 0.209 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.161687e-01 | 0.500 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.941564e-01 | 0.306 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.576658e-01 | 0.182 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.421949e-01 | 0.847 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.987590e-01 | 0.223 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.987590e-01 | 0.223 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.212914e-01 | 0.493 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.206212e-01 | 0.376 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.382315e-01 | 0.269 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.102620e-01 | 0.677 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.965053e-01 | 0.402 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.355256e-01 | 0.361 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.738682e-01 | 0.324 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.292067e-01 | 0.367 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.819617e-01 | 0.740 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.535192e-01 | 0.343 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.622523e-01 | 0.250 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.456722e-01 | 0.263 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.920053e-01 | 0.228 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.646766e-01 | 0.177 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.808765e-01 | 0.551 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.198151e-01 | 0.377 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.586811e-01 | 0.181 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.210302e-01 | 0.493 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.862692e-01 | 0.232 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.622523e-01 | 0.250 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.109930e-01 | 0.214 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.109930e-01 | 0.214 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.415500e-01 | 0.193 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.415500e-01 | 0.193 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.748741e-01 | 0.561 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.389857e-01 | 0.857 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.914189e-01 | 0.535 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.600846e-01 | 0.337 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.268960e-01 | 0.644 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.108826e-01 | 0.676 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.665774e-01 | 0.574 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.484702e-01 | 0.605 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.971171e-01 | 0.304 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.172173e-01 | 0.286 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.957152e-01 | 0.225 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.987590e-01 | 0.223 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.348083e-01 | 0.197 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.809191e-01 | 0.236 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.244075e-01 | 0.205 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.519023e-01 | 0.258 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.630225e-01 | 0.580 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.035607e-01 | 0.691 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.965144e-01 | 0.402 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.107186e-01 | 0.386 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.488358e-01 | 0.827 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.830359e-01 | 0.316 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.692789e-01 | 0.174 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.806153e-01 | 0.318 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.083970e-01 | 0.511 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.981280e-01 | 0.526 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.005448e-01 | 0.698 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.762592e-01 | 0.425 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.996557e-01 | 0.700 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 3.724669e-01 | 0.429 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.136922e-01 | 0.383 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.074083e-01 | 0.295 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.535192e-01 | 0.343 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.622523e-01 | 0.250 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.720200e-01 | 0.326 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.456722e-01 | 0.263 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.266340e-01 | 0.203 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.266340e-01 | 0.203 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.971171e-01 | 0.304 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.904910e-01 | 0.309 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.173213e-01 | 0.209 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.034925e-01 | 0.219 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.886125e-01 | 0.724 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.024939e-01 | 0.519 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.423478e-01 | 0.847 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.888427e-01 | 0.724 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.679556e-01 | 0.434 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.725709e-01 | 0.242 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.456970e-01 | 0.351 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.408929e-01 | 0.851 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.568173e-01 | 0.448 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.136922e-01 | 0.383 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.102620e-01 | 0.677 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.728054e-01 | 0.172 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.556825e-01 | 0.183 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.250501e-01 | 0.372 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.885150e-01 | 0.411 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.556825e-01 | 0.183 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.107186e-01 | 0.386 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.456722e-01 | 0.263 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.074083e-01 | 0.295 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.423001e-01 | 0.354 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.109930e-01 | 0.214 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 6.109930e-01 | 0.214 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.543093e-01 | 0.184 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.314080e-01 | 0.200 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.748754e-01 | 0.171 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.940042e-01 | 0.404 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.724811e-01 | 0.763 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.469955e-01 | 0.607 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.629136e-01 | 0.250 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.927299e-01 | 0.227 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.415500e-01 | 0.193 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.123504e-01 | 0.213 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.136155e-01 | 0.212 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.415500e-01 | 0.193 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.961173e-01 | 0.707 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.917486e-01 | 0.308 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.648963e-01 | 0.333 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.629136e-01 | 0.250 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.109930e-01 | 0.214 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.109930e-01 | 0.214 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.109930e-01 | 0.214 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.543093e-01 | 0.184 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.543093e-01 | 0.184 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 3.568173e-01 | 0.448 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.307584e-01 | 0.275 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.314080e-01 | 0.200 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 5.382775e-01 | 0.269 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 5.382775e-01 | 0.269 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.555339e-01 | 0.449 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.382315e-01 | 0.269 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.457513e-01 | 0.351 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.903774e-01 | 0.537 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.292143e-01 | 0.276 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.872078e-01 | 0.312 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.957152e-01 | 0.225 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.535192e-01 | 0.343 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.792956e-01 | 0.168 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.823697e-01 | 0.166 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.828937e-01 | 0.166 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.828937e-01 | 0.166 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.828937e-01 | 0.166 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.828937e-01 | 0.166 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.850274e-01 | 0.164 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.850274e-01 | 0.164 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.866966e-01 | 0.163 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.866966e-01 | 0.163 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.928045e-01 | 0.159 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.928045e-01 | 0.159 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.928045e-01 | 0.159 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.928045e-01 | 0.159 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.928045e-01 | 0.159 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.928045e-01 | 0.159 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.928045e-01 | 0.159 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.928045e-01 | 0.159 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.928045e-01 | 0.159 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.928045e-01 | 0.159 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.928045e-01 | 0.159 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.928045e-01 | 0.159 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.928045e-01 | 0.159 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.928045e-01 | 0.159 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.928045e-01 | 0.159 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.928045e-01 | 0.159 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.937271e-01 | 0.159 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.937271e-01 | 0.159 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.937271e-01 | 0.159 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.948042e-01 | 0.158 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.968871e-01 | 0.157 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.024108e-01 | 0.153 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.041237e-01 | 0.152 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.041237e-01 | 0.152 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.076148e-01 | 0.150 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.076148e-01 | 0.150 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.076148e-01 | 0.150 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.083167e-01 | 0.150 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 7.083167e-01 | 0.150 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.083167e-01 | 0.150 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.083167e-01 | 0.150 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.083167e-01 | 0.150 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.083167e-01 | 0.150 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.083167e-01 | 0.150 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 7.088569e-01 | 0.149 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.098049e-01 | 0.149 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.117849e-01 | 0.148 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.117849e-01 | 0.148 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.117849e-01 | 0.148 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.117849e-01 | 0.148 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.129822e-01 | 0.147 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.129822e-01 | 0.147 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.135402e-01 | 0.147 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.135402e-01 | 0.147 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.150856e-01 | 0.146 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.177065e-01 | 0.144 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.178255e-01 | 0.144 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.178255e-01 | 0.144 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.242938e-01 | 0.140 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.270150e-01 | 0.138 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.270150e-01 | 0.138 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.270150e-01 | 0.138 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.270150e-01 | 0.138 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.270150e-01 | 0.138 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.270150e-01 | 0.138 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.270150e-01 | 0.138 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.270150e-01 | 0.138 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.270150e-01 | 0.138 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.270150e-01 | 0.138 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.270150e-01 | 0.138 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.270150e-01 | 0.138 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.270150e-01 | 0.138 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.274434e-01 | 0.138 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.274434e-01 | 0.138 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.274434e-01 | 0.138 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.290074e-01 | 0.137 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.290506e-01 | 0.137 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.290506e-01 | 0.137 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.304463e-01 | 0.136 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.320122e-01 | 0.135 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.320122e-01 | 0.135 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.320122e-01 | 0.135 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.370483e-01 | 0.133 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.370483e-01 | 0.133 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.370483e-01 | 0.133 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.382691e-01 | 0.132 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.439188e-01 | 0.128 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.455301e-01 | 0.128 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.462011e-01 | 0.127 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.462011e-01 | 0.127 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.462011e-01 | 0.127 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.462011e-01 | 0.127 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.462011e-01 | 0.127 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.470257e-01 | 0.127 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.533617e-01 | 0.123 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.540495e-01 | 0.123 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.540495e-01 | 0.123 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.540495e-01 | 0.123 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.540495e-01 | 0.123 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.540495e-01 | 0.123 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.540495e-01 | 0.123 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.540495e-01 | 0.123 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.540495e-01 | 0.123 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.574174e-01 | 0.121 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.574174e-01 | 0.121 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.574174e-01 | 0.121 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.574174e-01 | 0.121 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.574174e-01 | 0.121 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.574174e-01 | 0.121 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.574174e-01 | 0.121 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.574174e-01 | 0.121 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.574174e-01 | 0.121 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.574174e-01 | 0.121 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.612329e-01 | 0.118 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.612620e-01 | 0.118 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.620675e-01 | 0.118 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.620675e-01 | 0.118 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.639120e-01 | 0.117 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.646821e-01 | 0.117 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.646821e-01 | 0.117 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.646821e-01 | 0.117 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.667541e-01 | 0.115 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.667541e-01 | 0.115 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.667541e-01 | 0.115 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.672312e-01 | 0.115 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.745041e-01 | 0.111 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.745041e-01 | 0.111 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.745041e-01 | 0.111 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.756268e-01 | 0.110 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.756268e-01 | 0.110 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.761717e-01 | 0.110 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.767362e-01 | 0.110 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.767871e-01 | 0.110 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.771257e-01 | 0.110 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.778149e-01 | 0.109 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.806047e-01 | 0.108 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.806047e-01 | 0.108 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.806047e-01 | 0.108 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.844355e-01 | 0.105 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.844355e-01 | 0.105 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.844355e-01 | 0.105 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.844355e-01 | 0.105 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.844355e-01 | 0.105 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.844355e-01 | 0.105 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.844355e-01 | 0.105 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.844355e-01 | 0.105 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.844355e-01 | 0.105 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.844355e-01 | 0.105 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.868650e-01 | 0.104 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.868650e-01 | 0.104 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.890675e-01 | 0.103 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.903622e-01 | 0.102 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.903622e-01 | 0.102 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.914996e-01 | 0.102 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.934551e-01 | 0.100 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.934551e-01 | 0.100 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.934551e-01 | 0.100 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.934551e-01 | 0.100 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.934551e-01 | 0.100 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.934551e-01 | 0.100 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.934551e-01 | 0.100 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.934551e-01 | 0.100 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.934551e-01 | 0.100 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.934551e-01 | 0.100 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.949146e-01 | 0.100 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.949146e-01 | 0.100 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.005143e-01 | 0.097 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.009524e-01 | 0.096 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.034556e-01 | 0.095 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.038222e-01 | 0.095 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.058624e-01 | 0.094 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.084458e-01 | 0.092 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.084458e-01 | 0.092 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.084458e-01 | 0.092 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.084458e-01 | 0.092 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 8.084458e-01 | 0.092 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.084458e-01 | 0.092 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.084458e-01 | 0.092 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.084458e-01 | 0.092 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.084458e-01 | 0.092 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.084458e-01 | 0.092 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.084458e-01 | 0.092 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.084458e-01 | 0.092 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.088567e-01 | 0.092 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.088567e-01 | 0.092 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.109836e-01 | 0.091 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.109836e-01 | 0.091 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.110659e-01 | 0.091 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.110697e-01 | 0.091 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.110697e-01 | 0.091 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.117722e-01 | 0.091 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 8.117722e-01 | 0.091 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.117722e-01 | 0.091 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.127413e-01 | 0.090 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.130712e-01 | 0.090 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.165715e-01 | 0.088 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.165715e-01 | 0.088 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.165715e-01 | 0.088 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.165715e-01 | 0.088 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.165715e-01 | 0.088 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.186223e-01 | 0.087 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.219561e-01 | 0.085 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.237683e-01 | 0.084 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.249059e-01 | 0.084 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.271713e-01 | 0.082 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.271713e-01 | 0.082 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.271713e-01 | 0.082 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.271713e-01 | 0.082 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.279925e-01 | 0.082 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.286315e-01 | 0.082 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.286315e-01 | 0.082 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.286315e-01 | 0.082 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.286315e-01 | 0.082 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.286315e-01 | 0.082 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.297830e-01 | 0.081 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.297830e-01 | 0.081 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.297830e-01 | 0.081 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.297830e-01 | 0.081 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.297830e-01 | 0.081 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.297830e-01 | 0.081 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.297830e-01 | 0.081 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.297830e-01 | 0.081 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.297830e-01 | 0.081 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.319702e-01 | 0.080 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.321866e-01 | 0.080 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.346380e-01 | 0.079 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.346380e-01 | 0.079 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.355941e-01 | 0.078 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.355941e-01 | 0.078 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.378692e-01 | 0.077 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.378692e-01 | 0.077 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.397579e-01 | 0.076 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.400248e-01 | 0.076 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.400248e-01 | 0.076 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.400486e-01 | 0.076 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.415275e-01 | 0.075 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.420993e-01 | 0.075 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.429353e-01 | 0.074 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.447692e-01 | 0.073 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.447758e-01 | 0.073 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.447758e-01 | 0.073 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.451991e-01 | 0.073 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.478444e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.486844e-01 | 0.071 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.487446e-01 | 0.071 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.487446e-01 | 0.071 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.487446e-01 | 0.071 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.487446e-01 | 0.071 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.487446e-01 | 0.071 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.487446e-01 | 0.071 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.487446e-01 | 0.071 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.487446e-01 | 0.071 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.487446e-01 | 0.071 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.487446e-01 | 0.071 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.487446e-01 | 0.071 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.487446e-01 | 0.071 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.487446e-01 | 0.071 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.487446e-01 | 0.071 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.488277e-01 | 0.071 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.499950e-01 | 0.071 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.499950e-01 | 0.071 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.506395e-01 | 0.070 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.507751e-01 | 0.070 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.507751e-01 | 0.070 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.542856e-01 | 0.068 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.543946e-01 | 0.068 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.558131e-01 | 0.068 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.558474e-01 | 0.068 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.558474e-01 | 0.068 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.558474e-01 | 0.068 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.558474e-01 | 0.068 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.558474e-01 | 0.068 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.558474e-01 | 0.068 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.593184e-01 | 0.066 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.609065e-01 | 0.065 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.609065e-01 | 0.065 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.612671e-01 | 0.065 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.613226e-01 | 0.065 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.613226e-01 | 0.065 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.613226e-01 | 0.065 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.635114e-01 | 0.064 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.635114e-01 | 0.064 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.648263e-01 | 0.063 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.655949e-01 | 0.063 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.655949e-01 | 0.063 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.655949e-01 | 0.063 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.655949e-01 | 0.063 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.655949e-01 | 0.063 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.655949e-01 | 0.063 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.655949e-01 | 0.063 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.655949e-01 | 0.063 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.670869e-01 | 0.062 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.697804e-01 | 0.061 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.704439e-01 | 0.060 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 8.704439e-01 | 0.060 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.704439e-01 | 0.060 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.714689e-01 | 0.060 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.721434e-01 | 0.059 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.754280e-01 | 0.058 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.793590e-01 | 0.056 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.794123e-01 | 0.056 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.795280e-01 | 0.056 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.801114e-01 | 0.055 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.801114e-01 | 0.055 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.801114e-01 | 0.055 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.803081e-01 | 0.055 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.805689e-01 | 0.055 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.805689e-01 | 0.055 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.805689e-01 | 0.055 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.805689e-01 | 0.055 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.805689e-01 | 0.055 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.805689e-01 | 0.055 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.805689e-01 | 0.055 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.805689e-01 | 0.055 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.805689e-01 | 0.055 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.805689e-01 | 0.055 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.805689e-01 | 0.055 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.817415e-01 | 0.055 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.817415e-01 | 0.055 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.817415e-01 | 0.055 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.817415e-01 | 0.055 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.817415e-01 | 0.055 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.826621e-01 | 0.054 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.840295e-01 | 0.054 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.874011e-01 | 0.052 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.878367e-01 | 0.052 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.878367e-01 | 0.052 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.886971e-01 | 0.051 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.907742e-01 | 0.050 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.907742e-01 | 0.050 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.907742e-01 | 0.050 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 8.907742e-01 | 0.050 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.907742e-01 | 0.050 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.907742e-01 | 0.050 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.909107e-01 | 0.050 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.909107e-01 | 0.050 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.909107e-01 | 0.050 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.909107e-01 | 0.050 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.909107e-01 | 0.050 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.927309e-01 | 0.049 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.928235e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.928733e-01 | 0.049 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.928733e-01 | 0.049 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.928733e-01 | 0.049 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.938755e-01 | 0.049 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.938755e-01 | 0.049 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.938755e-01 | 0.049 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.938755e-01 | 0.049 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.938755e-01 | 0.049 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.938755e-01 | 0.049 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.938755e-01 | 0.049 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.938755e-01 | 0.049 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.938755e-01 | 0.049 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.938755e-01 | 0.049 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.938755e-01 | 0.049 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.938755e-01 | 0.049 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.987715e-01 | 0.046 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.994373e-01 | 0.046 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.005501e-01 | 0.045 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.005501e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.005501e-01 | 0.045 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.005501e-01 | 0.045 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.021777e-01 | 0.045 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.057001e-01 | 0.043 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.057001e-01 | 0.043 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.057001e-01 | 0.043 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.057001e-01 | 0.043 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.057001e-01 | 0.043 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.057001e-01 | 0.043 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.057001e-01 | 0.043 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.057001e-01 | 0.043 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.057001e-01 | 0.043 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.057001e-01 | 0.043 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.073583e-01 | 0.042 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.095044e-01 | 0.041 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.095044e-01 | 0.041 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.095044e-01 | 0.041 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.100940e-01 | 0.041 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.113240e-01 | 0.040 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.117717e-01 | 0.040 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.147095e-01 | 0.039 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.147095e-01 | 0.039 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.147095e-01 | 0.039 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.147352e-01 | 0.039 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.147482e-01 | 0.039 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.162079e-01 | 0.038 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.162079e-01 | 0.038 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.162079e-01 | 0.038 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.162079e-01 | 0.038 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 9.162079e-01 | 0.038 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.162079e-01 | 0.038 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.162079e-01 | 0.038 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.162079e-01 | 0.038 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.162079e-01 | 0.038 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.165889e-01 | 0.038 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.165889e-01 | 0.038 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.165889e-01 | 0.038 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.176986e-01 | 0.037 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.176986e-01 | 0.037 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.180789e-01 | 0.037 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.180789e-01 | 0.037 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.190519e-01 | 0.037 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.191351e-01 | 0.037 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.215254e-01 | 0.035 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.223859e-01 | 0.035 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.226609e-01 | 0.035 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.251910e-01 | 0.034 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.251910e-01 | 0.034 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.251910e-01 | 0.034 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 9.255453e-01 | 0.034 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.255453e-01 | 0.034 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.255453e-01 | 0.034 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.255453e-01 | 0.034 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.255453e-01 | 0.034 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.255453e-01 | 0.034 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.255453e-01 | 0.034 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.258743e-01 | 0.033 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.278396e-01 | 0.033 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.278396e-01 | 0.033 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.278396e-01 | 0.033 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.278396e-01 | 0.033 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.278396e-01 | 0.033 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.283327e-01 | 0.032 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.283327e-01 | 0.032 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.290483e-01 | 0.032 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.296060e-01 | 0.032 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.320362e-01 | 0.031 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.320362e-01 | 0.031 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.320362e-01 | 0.031 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.320362e-01 | 0.031 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.320362e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.324502e-01 | 0.030 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.326011e-01 | 0.030 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.338427e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.338427e-01 | 0.030 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.338427e-01 | 0.030 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.338427e-01 | 0.030 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.338427e-01 | 0.030 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.338427e-01 | 0.030 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.338427e-01 | 0.030 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.345053e-01 | 0.029 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.362739e-01 | 0.029 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.382854e-01 | 0.028 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.382854e-01 | 0.028 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.382854e-01 | 0.028 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.383379e-01 | 0.028 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.385776e-01 | 0.028 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.390886e-01 | 0.027 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.394410e-01 | 0.027 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.411284e-01 | 0.026 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.411284e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.412158e-01 | 0.026 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.412158e-01 | 0.026 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.412158e-01 | 0.026 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.412158e-01 | 0.026 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.412158e-01 | 0.026 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.412158e-01 | 0.026 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.412158e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.431634e-01 | 0.025 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.431634e-01 | 0.025 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.432701e-01 | 0.025 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.439863e-01 | 0.025 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.439863e-01 | 0.025 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.440830e-01 | 0.025 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.443249e-01 | 0.025 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.443249e-01 | 0.025 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.465489e-01 | 0.024 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.475423e-01 | 0.023 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.477676e-01 | 0.023 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.477676e-01 | 0.023 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.486948e-01 | 0.023 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.486948e-01 | 0.023 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.486948e-01 | 0.023 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.486948e-01 | 0.023 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.486948e-01 | 0.023 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.491835e-01 | 0.023 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.491835e-01 | 0.023 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.491835e-01 | 0.023 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.491835e-01 | 0.023 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.491835e-01 | 0.023 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.491835e-01 | 0.023 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.496095e-01 | 0.022 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.496095e-01 | 0.022 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.500981e-01 | 0.022 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.525119e-01 | 0.021 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.529501e-01 | 0.021 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.535895e-01 | 0.021 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.535895e-01 | 0.021 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.535895e-01 | 0.021 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.535895e-01 | 0.021 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.535895e-01 | 0.021 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.535895e-01 | 0.021 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.535895e-01 | 0.021 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.535895e-01 | 0.021 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.535895e-01 | 0.021 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.539185e-01 | 0.020 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.539185e-01 | 0.020 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.539185e-01 | 0.020 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.539185e-01 | 0.020 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.539185e-01 | 0.020 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.539185e-01 | 0.020 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.539185e-01 | 0.020 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.547276e-01 | 0.020 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.551389e-01 | 0.020 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.551389e-01 | 0.020 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.551389e-01 | 0.020 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.553216e-01 | 0.020 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.568737e-01 | 0.019 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.582296e-01 | 0.019 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.582296e-01 | 0.019 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.582296e-01 | 0.019 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.582296e-01 | 0.019 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.582296e-01 | 0.019 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.587628e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.587628e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.587628e-01 | 0.018 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.587628e-01 | 0.018 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.604368e-01 | 0.018 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.604890e-01 | 0.018 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.610823e-01 | 0.017 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.621525e-01 | 0.017 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.629776e-01 | 0.016 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.633597e-01 | 0.016 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.633597e-01 | 0.016 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.633597e-01 | 0.016 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.633597e-01 | 0.016 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.633597e-01 | 0.016 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.633597e-01 | 0.016 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.633597e-01 | 0.016 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.633597e-01 | 0.016 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.633597e-01 | 0.016 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.636118e-01 | 0.016 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.643003e-01 | 0.016 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.657202e-01 | 0.015 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.657202e-01 | 0.015 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.657202e-01 | 0.015 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.657202e-01 | 0.015 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.674445e-01 | 0.014 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.674445e-01 | 0.014 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.674445e-01 | 0.014 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.674445e-01 | 0.014 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.674445e-01 | 0.014 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.674445e-01 | 0.014 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.674707e-01 | 0.014 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.680534e-01 | 0.014 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.682281e-01 | 0.014 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.689631e-01 | 0.014 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.696989e-01 | 0.013 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.700495e-01 | 0.013 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.700523e-01 | 0.013 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 9.710740e-01 | 0.013 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.710740e-01 | 0.013 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.710740e-01 | 0.013 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.710740e-01 | 0.013 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.710740e-01 | 0.013 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.710740e-01 | 0.013 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.710740e-01 | 0.013 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.710740e-01 | 0.013 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.716677e-01 | 0.012 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.719093e-01 | 0.012 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.719093e-01 | 0.012 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.722884e-01 | 0.012 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.722884e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.723041e-01 | 0.012 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.723041e-01 | 0.012 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.724118e-01 | 0.012 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.732044e-01 | 0.012 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.736954e-01 | 0.012 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.742991e-01 | 0.011 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.742991e-01 | 0.011 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.742991e-01 | 0.011 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.742991e-01 | 0.011 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.742991e-01 | 0.011 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.742991e-01 | 0.011 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.742991e-01 | 0.011 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.742991e-01 | 0.011 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.742991e-01 | 0.011 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.745845e-01 | 0.011 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.745845e-01 | 0.011 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.745845e-01 | 0.011 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.745987e-01 | 0.011 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.746657e-01 | 0.011 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.746671e-01 | 0.011 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.750350e-01 | 0.011 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.766220e-01 | 0.010 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.768510e-01 | 0.010 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.770126e-01 | 0.010 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.770126e-01 | 0.010 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.770126e-01 | 0.010 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.771648e-01 | 0.010 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.771648e-01 | 0.010 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.771648e-01 | 0.010 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.771648e-01 | 0.010 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.771648e-01 | 0.010 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.784659e-01 | 0.009 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.784929e-01 | 0.009 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.792154e-01 | 0.009 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.797111e-01 | 0.009 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.797111e-01 | 0.009 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.797111e-01 | 0.009 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.797111e-01 | 0.009 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.797111e-01 | 0.009 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.797111e-01 | 0.009 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.797111e-01 | 0.009 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.803782e-01 | 0.009 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.803782e-01 | 0.009 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.812130e-01 | 0.008 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.812130e-01 | 0.008 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.812130e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.817896e-01 | 0.008 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.818192e-01 | 0.008 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.818245e-01 | 0.008 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.819736e-01 | 0.008 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.819736e-01 | 0.008 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.819736e-01 | 0.008 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.819736e-01 | 0.008 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.819736e-01 | 0.008 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.819736e-01 | 0.008 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.819736e-01 | 0.008 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.819736e-01 | 0.008 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.822196e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.833500e-01 | 0.007 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.839839e-01 | 0.007 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.839839e-01 | 0.007 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.839839e-01 | 0.007 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.839839e-01 | 0.007 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.839839e-01 | 0.007 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.840014e-01 | 0.007 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.844594e-01 | 0.007 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.846642e-01 | 0.007 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.852587e-01 | 0.006 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.854757e-01 | 0.006 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.857701e-01 | 0.006 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.857701e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.857701e-01 | 0.006 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.861501e-01 | 0.006 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.861501e-01 | 0.006 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.866284e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.866284e-01 | 0.006 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.866710e-01 | 0.006 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.873572e-01 | 0.006 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.873572e-01 | 0.006 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.874955e-01 | 0.005 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.874955e-01 | 0.005 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.874955e-01 | 0.005 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.878122e-01 | 0.005 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.878122e-01 | 0.005 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.881333e-01 | 0.005 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.881333e-01 | 0.005 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.887132e-01 | 0.005 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.898148e-01 | 0.004 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.900204e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.900204e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.900204e-01 | 0.004 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.900204e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.901073e-01 | 0.004 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.903584e-01 | 0.004 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.905190e-01 | 0.004 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.908113e-01 | 0.004 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.908113e-01 | 0.004 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.908113e-01 | 0.004 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.908519e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.908519e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.911336e-01 | 0.004 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.916152e-01 | 0.004 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.921228e-01 | 0.003 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.921228e-01 | 0.003 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.921228e-01 | 0.003 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.925266e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.930016e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.930016e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.930016e-01 | 0.003 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.930016e-01 | 0.003 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.932624e-01 | 0.003 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.933513e-01 | 0.003 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.937387e-01 | 0.003 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.937824e-01 | 0.003 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.938438e-01 | 0.003 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.938886e-01 | 0.003 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.943006e-01 | 0.002 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.944762e-01 | 0.002 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.944762e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.944762e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.947815e-01 | 0.002 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.947860e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.950926e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.951448e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.954585e-01 | 0.002 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.954799e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.956402e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.956402e-01 | 0.002 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.956913e-01 | 0.002 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.958802e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.960002e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.960002e-01 | 0.002 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.961267e-01 | 0.002 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.962342e-01 | 0.002 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.963385e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.964892e-01 | 0.002 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.965444e-01 | 0.002 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.965595e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.967578e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.967737e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.968575e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.969431e-01 | 0.001 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.970717e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.970817e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.970817e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.970817e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.970817e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.971304e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.972843e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.972843e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.973338e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.973803e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.974955e-01 | 0.001 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.975846e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.975874e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.975874e-01 | 0.001 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.975894e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.976370e-01 | 0.001 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.978067e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.978184e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.978184e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.978567e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.983086e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.983141e-01 | 0.001 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.983451e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.984753e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.984914e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.985236e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.986099e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.986099e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.986652e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.986652e-01 | 0.001 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.986916e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.987504e-01 | 0.001 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.987718e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.988143e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.988952e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.989025e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.989075e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.990643e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.990643e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.990932e-01 | 0.000 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.991003e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.991383e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.991800e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.991853e-01 | 0.000 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.992598e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.992863e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.993332e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.993427e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994097e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.994174e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.994825e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.994825e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.995065e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.995559e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.995728e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.995916e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.995961e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.996166e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.996373e-01 | 0.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.996744e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997138e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997138e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.997742e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.997742e-01 | 0.000 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.998091e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.998187e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998218e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.998304e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998391e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998595e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998917e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998960e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999060e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999078e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.999125e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999125e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.999125e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999223e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999303e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999310e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999399e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999410e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999456e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.999476e-01 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.999476e-01 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.999476e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999477e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.999477e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.999619e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999674e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999689e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999733e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999786e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999813e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999840e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999884e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999918e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999926e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999932e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999934e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999935e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999949e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999954e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999958e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999962e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999968e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999970e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999971e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999974e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999981e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999983e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999983e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.999987e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999992e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999993e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999993e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999995e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999996e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999999e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.953959e-11 | 10.530 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.335499e-08 | 7.632 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.553731e-08 | 7.593 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.034053e-07 | 6.985 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.100485e-07 | 6.678 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.580733e-07 | 6.588 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.488211e-07 | 6.126 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.611573e-07 | 6.065 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.242812e-06 | 5.906 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.623227e-06 | 5.335 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.204880e-06 | 5.142 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.106761e-05 | 4.956 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.225014e-05 | 4.912 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.473193e-05 | 4.832 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.197082e-05 | 4.658 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.220369e-05 | 4.282 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.220369e-05 | 4.282 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.519472e-05 | 4.186 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.667989e-05 | 4.176 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.006613e-05 | 4.097 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.645481e-05 | 4.016 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.645481e-05 | 4.016 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.006622e-04 | 3.997 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.255610e-04 | 3.901 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.255610e-04 | 3.901 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.253229e-04 | 3.902 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.383683e-04 | 3.859 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.800941e-04 | 3.745 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.841613e-04 | 3.735 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.001048e-04 | 3.699 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.036101e-04 | 3.691 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.320983e-04 | 3.634 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.519519e-04 | 3.599 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.868714e-04 | 3.542 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.961412e-04 | 3.529 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.077555e-04 | 3.512 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.465052e-04 | 3.460 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.410853e-04 | 3.467 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.688508e-04 | 3.433 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.005214e-04 | 3.397 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.306104e-04 | 3.366 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.212209e-04 | 3.283 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.212209e-04 | 3.283 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.402243e-04 | 3.267 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.703881e-04 | 3.244 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.445859e-04 | 3.191 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.567189e-04 | 3.183 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.718282e-04 | 3.173 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.946293e-04 | 3.158 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.265236e-04 | 3.139 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.362002e-04 | 3.133 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.966054e-04 | 3.001 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.170026e-03 | 2.932 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.174646e-03 | 2.930 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.389478e-03 | 2.857 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.409292e-03 | 2.851 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.376893e-03 | 2.861 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.420644e-03 | 2.848 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.420644e-03 | 2.848 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.425835e-03 | 2.846 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.579470e-03 | 2.801 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.741174e-03 | 2.759 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.794330e-03 | 2.746 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.920747e-03 | 2.717 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.295571e-03 | 2.639 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.419451e-03 | 2.616 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.436487e-03 | 2.613 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.534577e-03 | 2.596 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.554381e-03 | 2.593 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.804500e-03 | 2.552 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.850520e-03 | 2.545 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.094554e-03 | 2.509 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.094554e-03 | 2.509 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.188003e-03 | 2.496 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.210568e-03 | 2.493 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.538512e-03 | 2.451 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.538512e-03 | 2.451 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.430837e-03 | 2.465 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.811376e-03 | 2.419 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.160077e-03 | 2.381 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.550464e-03 | 2.342 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.446159e-03 | 2.352 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.458178e-03 | 2.351 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.540789e-03 | 2.343 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.383795e-03 | 2.358 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.458178e-03 | 2.351 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.557885e-03 | 2.341 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.550464e-03 | 2.342 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.446159e-03 | 2.352 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.696563e-03 | 2.328 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.891565e-03 | 2.311 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.891565e-03 | 2.311 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 4.904559e-03 | 2.309 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.916848e-03 | 2.308 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.457189e-03 | 2.263 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.322255e-03 | 2.274 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.276887e-03 | 2.278 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.924134e-03 | 2.227 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.939464e-03 | 2.226 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.939464e-03 | 2.226 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.939464e-03 | 2.226 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.822765e-03 | 2.235 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.822765e-03 | 2.235 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.939464e-03 | 2.226 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.706599e-03 | 2.244 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.020254e-03 | 2.220 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.623998e-03 | 2.250 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.350712e-03 | 2.197 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.513417e-03 | 2.186 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.624917e-03 | 2.179 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.021124e-03 | 2.154 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.021124e-03 | 2.154 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.725110e-03 | 2.112 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.299135e-03 | 2.137 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.655028e-03 | 2.116 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.655028e-03 | 2.116 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.458574e-03 | 2.127 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.898412e-03 | 2.102 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.090971e-03 | 2.041 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.352854e-03 | 2.029 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.660046e-03 | 2.015 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.853674e-03 | 2.006 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.890166e-03 | 2.005 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.994399e-03 | 2.000 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.994399e-03 | 2.000 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.015321e-02 | 1.993 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.064127e-02 | 1.973 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.086615e-02 | 1.964 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.187625e-02 | 1.925 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.105920e-02 | 1.956 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.124928e-02 | 1.949 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.187625e-02 | 1.925 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.214139e-02 | 1.916 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.233109e-02 | 1.909 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.237615e-02 | 1.907 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.237615e-02 | 1.907 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.274311e-02 | 1.895 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.306947e-02 | 1.884 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.437863e-02 | 1.842 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.332095e-02 | 1.875 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.409046e-02 | 1.851 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.398306e-02 | 1.854 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.402885e-02 | 1.853 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.313073e-02 | 1.882 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.306947e-02 | 1.884 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.450315e-02 | 1.839 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.476694e-02 | 1.831 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.479146e-02 | 1.830 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.554603e-02 | 1.808 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.554603e-02 | 1.808 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.554603e-02 | 1.808 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.554603e-02 | 1.808 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.554603e-02 | 1.808 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.554603e-02 | 1.808 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.554603e-02 | 1.808 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.540336e-02 | 1.812 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.540336e-02 | 1.812 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.540336e-02 | 1.812 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.545430e-02 | 1.811 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.609559e-02 | 1.793 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.562840e-02 | 1.806 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.562840e-02 | 1.806 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.689792e-02 | 1.772 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.590430e-02 | 1.798 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.702996e-02 | 1.769 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.773956e-02 | 1.751 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.818543e-02 | 1.740 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.874051e-02 | 1.727 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.874051e-02 | 1.727 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.959391e-02 | 1.708 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.998809e-02 | 1.699 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.998809e-02 | 1.699 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.036195e-02 | 1.691 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.098036e-02 | 1.678 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.235735e-02 | 1.651 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.371379e-02 | 1.625 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.563837e-02 | 1.591 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.424158e-02 | 1.615 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.425953e-02 | 1.615 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.360552e-02 | 1.627 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.424158e-02 | 1.615 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.525218e-02 | 1.598 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.329018e-02 | 1.633 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.490366e-02 | 1.604 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.490366e-02 | 1.604 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.551662e-02 | 1.593 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.374353e-02 | 1.624 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.703607e-02 | 1.568 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.765113e-02 | 1.558 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.765113e-02 | 1.558 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.765113e-02 | 1.558 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.765113e-02 | 1.558 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.890296e-02 | 1.539 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.906867e-02 | 1.537 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.906867e-02 | 1.537 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.918773e-02 | 1.535 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.981159e-02 | 1.526 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.044678e-02 | 1.516 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.044678e-02 | 1.516 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.117039e-02 | 1.506 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.213560e-02 | 1.493 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.239037e-02 | 1.490 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.241841e-02 | 1.489 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.273270e-02 | 1.485 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.290070e-02 | 1.483 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.407148e-02 | 1.468 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.545092e-02 | 1.450 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.545092e-02 | 1.450 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.601375e-02 | 1.444 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.055289e-02 | 1.392 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.055289e-02 | 1.392 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.844563e-02 | 1.415 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.777374e-02 | 1.423 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 4.055289e-02 | 1.392 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.207976e-02 | 1.376 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.988430e-02 | 1.399 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.670321e-02 | 1.435 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.210656e-02 | 1.376 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.439713e-02 | 1.353 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.492015e-02 | 1.348 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.493908e-02 | 1.347 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.620830e-02 | 1.335 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.633972e-02 | 1.334 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.633972e-02 | 1.334 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.806371e-02 | 1.318 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.956487e-02 | 1.305 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.973230e-02 | 1.303 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.991494e-02 | 1.302 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.991494e-02 | 1.302 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.991494e-02 | 1.302 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.504328e-02 | 1.259 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 5.504328e-02 | 1.259 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.504328e-02 | 1.259 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.504328e-02 | 1.259 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.504328e-02 | 1.259 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.504328e-02 | 1.259 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.091721e-02 | 1.293 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.828022e-02 | 1.234 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.533814e-02 | 1.257 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.074839e-02 | 1.295 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.524364e-02 | 1.258 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.467322e-02 | 1.262 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.467322e-02 | 1.262 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.463573e-02 | 1.263 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.035526e-02 | 1.219 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.299292e-02 | 1.276 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.828022e-02 | 1.234 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.630943e-02 | 1.249 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.345206e-02 | 1.272 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.019575e-02 | 1.220 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.828022e-02 | 1.234 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.120752e-02 | 1.213 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.240710e-02 | 1.205 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.291899e-02 | 1.201 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.440628e-02 | 1.191 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.571651e-02 | 1.182 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.571651e-02 | 1.182 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.571651e-02 | 1.182 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.603611e-02 | 1.180 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.603611e-02 | 1.180 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.624675e-02 | 1.179 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.624675e-02 | 1.179 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.627284e-02 | 1.179 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.653813e-02 | 1.177 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.783950e-02 | 1.169 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.925864e-02 | 1.160 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.925864e-02 | 1.160 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.925864e-02 | 1.160 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.023790e-02 | 1.153 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.028879e-02 | 1.153 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.028879e-02 | 1.153 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.123420e-02 | 1.147 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 8.097796e-02 | 1.092 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 8.097796e-02 | 1.092 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 8.097796e-02 | 1.092 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 8.097796e-02 | 1.092 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.624973e-02 | 1.064 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 8.624973e-02 | 1.064 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.624973e-02 | 1.064 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.624973e-02 | 1.064 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.624973e-02 | 1.064 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.804714e-02 | 1.108 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.809271e-02 | 1.107 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.398672e-02 | 1.076 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.633184e-02 | 1.064 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.907673e-02 | 1.102 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.907673e-02 | 1.102 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.756881e-02 | 1.110 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.533908e-02 | 1.123 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.804266e-02 | 1.108 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.194970e-02 | 1.143 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.809271e-02 | 1.107 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 7.374928e-02 | 1.132 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.486946e-02 | 1.071 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.904411e-02 | 1.050 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.907673e-02 | 1.102 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.398672e-02 | 1.076 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 8.097796e-02 | 1.092 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.847776e-02 | 1.105 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.804714e-02 | 1.108 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.660916e-02 | 1.062 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.224481e-02 | 1.141 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.904411e-02 | 1.050 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 8.097796e-02 | 1.092 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.804714e-02 | 1.108 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.804714e-02 | 1.108 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.222124e-02 | 1.141 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.365202e-02 | 1.133 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.956827e-02 | 1.048 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 8.956827e-02 | 1.048 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 8.956827e-02 | 1.048 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.991117e-02 | 1.046 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.374902e-02 | 1.028 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.510167e-02 | 1.022 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.632535e-02 | 1.016 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.832221e-02 | 1.007 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.009336e-01 | 0.996 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.009336e-01 | 0.996 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.033472e-01 | 0.986 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.040929e-01 | 0.983 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.040929e-01 | 0.983 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.040929e-01 | 0.983 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.048082e-01 | 0.980 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.048082e-01 | 0.980 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.048082e-01 | 0.980 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.048082e-01 | 0.980 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.048082e-01 | 0.980 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.048082e-01 | 0.980 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.048082e-01 | 0.980 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.058523e-01 | 0.975 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.058523e-01 | 0.975 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.058523e-01 | 0.975 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.082602e-01 | 0.966 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.098487e-01 | 0.959 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.098487e-01 | 0.959 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.098487e-01 | 0.959 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.098487e-01 | 0.959 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.098487e-01 | 0.959 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.409223e-01 | 0.851 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.409223e-01 | 0.851 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.409223e-01 | 0.851 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.409223e-01 | 0.851 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.409223e-01 | 0.851 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.409223e-01 | 0.851 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.247732e-01 | 0.904 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.247732e-01 | 0.904 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.247732e-01 | 0.904 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.212179e-01 | 0.916 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.212179e-01 | 0.916 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.140569e-01 | 0.943 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.384572e-01 | 0.859 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.166036e-01 | 0.933 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.251933e-01 | 0.902 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.147545e-01 | 0.940 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.364913e-01 | 0.865 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.364913e-01 | 0.865 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.459953e-01 | 0.836 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.311035e-01 | 0.882 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.240540e-01 | 0.906 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.458737e-01 | 0.836 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.264655e-01 | 0.898 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.101933e-01 | 0.958 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.406096e-01 | 0.852 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.302394e-01 | 0.885 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.247732e-01 | 0.904 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.241572e-01 | 0.906 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.307958e-01 | 0.883 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.098487e-01 | 0.959 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.247732e-01 | 0.904 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.226831e-01 | 0.911 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.244126e-01 | 0.905 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.101933e-01 | 0.958 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.459953e-01 | 0.836 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.409223e-01 | 0.851 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.264655e-01 | 0.898 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.319380e-01 | 0.880 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.141960e-01 | 0.942 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.121592e-01 | 0.950 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.212179e-01 | 0.916 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.162400e-01 | 0.935 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.280905e-01 | 0.892 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.302394e-01 | 0.885 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.121592e-01 | 0.950 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.098487e-01 | 0.959 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.341113e-01 | 0.873 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.364913e-01 | 0.865 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.119331e-01 | 0.951 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.311035e-01 | 0.882 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.279590e-01 | 0.893 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.459774e-01 | 0.836 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.170236e-01 | 0.932 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.464258e-01 | 0.834 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.496530e-01 | 0.825 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.509565e-01 | 0.821 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.510913e-01 | 0.821 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.711189e-01 | 0.767 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.711189e-01 | 0.767 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.711189e-01 | 0.767 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.711189e-01 | 0.767 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.711189e-01 | 0.767 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.711189e-01 | 0.767 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.453691e-01 | 0.610 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.453691e-01 | 0.610 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.453691e-01 | 0.610 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.453691e-01 | 0.610 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.453691e-01 | 0.610 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.453691e-01 | 0.610 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.735731e-01 | 0.761 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.735731e-01 | 0.761 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.735731e-01 | 0.761 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.735731e-01 | 0.761 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.129721e-01 | 0.504 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.129721e-01 | 0.504 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.129721e-01 | 0.504 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.129721e-01 | 0.504 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.072698e-01 | 0.683 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.682511e-01 | 0.774 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.682511e-01 | 0.774 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.415634e-01 | 0.617 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.415634e-01 | 0.617 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.415634e-01 | 0.617 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.415634e-01 | 0.617 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 2.415634e-01 | 0.617 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.745226e-01 | 0.427 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.745226e-01 | 0.427 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.745226e-01 | 0.427 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.745226e-01 | 0.427 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.745226e-01 | 0.427 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.914261e-01 | 0.718 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.914261e-01 | 0.718 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.914261e-01 | 0.718 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.914261e-01 | 0.718 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.914261e-01 | 0.718 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.545494e-01 | 0.811 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.545494e-01 | 0.811 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.545494e-01 | 0.811 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.760771e-01 | 0.559 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.153385e-01 | 0.667 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.153385e-01 | 0.667 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.723692e-01 | 0.764 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.544948e-01 | 0.811 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.908560e-01 | 0.719 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.104964e-01 | 0.508 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.104964e-01 | 0.508 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.104964e-01 | 0.508 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.305621e-01 | 0.366 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.305621e-01 | 0.366 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.305621e-01 | 0.366 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.305621e-01 | 0.366 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.305621e-01 | 0.366 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.305621e-01 | 0.366 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.099305e-01 | 0.678 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.647527e-01 | 0.577 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.647527e-01 | 0.577 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.295131e-01 | 0.639 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.295131e-01 | 0.639 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.445615e-01 | 0.463 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.010441e-01 | 0.697 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.010441e-01 | 0.697 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.010441e-01 | 0.697 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.010441e-01 | 0.697 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.899644e-01 | 0.538 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.573270e-01 | 0.803 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.495247e-01 | 0.603 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.175165e-01 | 0.663 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.175165e-01 | 0.663 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.912424e-01 | 0.718 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.912424e-01 | 0.718 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.343880e-01 | 0.630 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.698873e-01 | 0.569 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.153348e-01 | 0.501 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.780599e-01 | 0.422 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.201344e-01 | 0.657 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.201344e-01 | 0.657 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.516100e-01 | 0.599 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.516100e-01 | 0.599 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.350975e-01 | 0.629 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.633658e-01 | 0.787 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.691342e-01 | 0.570 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.108198e-01 | 0.386 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.108198e-01 | 0.386 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.108198e-01 | 0.386 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.631225e-01 | 0.787 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.186374e-01 | 0.660 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.660800e-01 | 0.436 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.323336e-01 | 0.478 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.028180e-01 | 0.693 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.816601e-01 | 0.550 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.912451e-01 | 0.408 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.912451e-01 | 0.408 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.427047e-01 | 0.354 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.412969e-01 | 0.467 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.412969e-01 | 0.467 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.744001e-01 | 0.427 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.570878e-01 | 0.590 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.300308e-01 | 0.481 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.161491e-01 | 0.381 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.161491e-01 | 0.381 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.161491e-01 | 0.381 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.161491e-01 | 0.381 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.161491e-01 | 0.381 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.879132e-01 | 0.541 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.343902e-01 | 0.476 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.651640e-01 | 0.782 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.493517e-01 | 0.457 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.162308e-01 | 0.381 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.182269e-01 | 0.497 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.794583e-01 | 0.421 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.958146e-01 | 0.403 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.958146e-01 | 0.403 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.945565e-01 | 0.404 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.122855e-01 | 0.385 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.122855e-01 | 0.385 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.508804e-01 | 0.346 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.012518e-01 | 0.397 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.570878e-01 | 0.590 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.835067e-01 | 0.547 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.201344e-01 | 0.657 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.940530e-01 | 0.712 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.499788e-01 | 0.456 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.220032e-01 | 0.375 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.199405e-01 | 0.658 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.098348e-01 | 0.509 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.622725e-01 | 0.790 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.508804e-01 | 0.346 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.660800e-01 | 0.436 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.816601e-01 | 0.550 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.816601e-01 | 0.550 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.516100e-01 | 0.599 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.385019e-01 | 0.470 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.385019e-01 | 0.470 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.723692e-01 | 0.764 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.146065e-01 | 0.382 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.488214e-01 | 0.348 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.385019e-01 | 0.470 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.533669e-01 | 0.452 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.153348e-01 | 0.501 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.254046e-01 | 0.647 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.182269e-01 | 0.497 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.914261e-01 | 0.718 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.694871e-01 | 0.771 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.912424e-01 | 0.718 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.508804e-01 | 0.346 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.108198e-01 | 0.386 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.976272e-01 | 0.526 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.350975e-01 | 0.629 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.793242e-01 | 0.421 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.369208e-01 | 0.360 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.901641e-01 | 0.537 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.201360e-01 | 0.657 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.161491e-01 | 0.381 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.744001e-01 | 0.427 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.647527e-01 | 0.577 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.113638e-01 | 0.507 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.723692e-01 | 0.764 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.458521e-01 | 0.609 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.628433e-01 | 0.440 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.628433e-01 | 0.440 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.682511e-01 | 0.774 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.398306e-01 | 0.620 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.104964e-01 | 0.508 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.445615e-01 | 0.463 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.445615e-01 | 0.463 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.899644e-01 | 0.538 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.912424e-01 | 0.718 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.055053e-01 | 0.687 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 3.407433e-01 | 0.468 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.869121e-01 | 0.542 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.328053e-01 | 0.364 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.723692e-01 | 0.764 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.939856e-01 | 0.712 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.850187e-01 | 0.733 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.689576e-01 | 0.772 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.162308e-01 | 0.381 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.901641e-01 | 0.537 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.901641e-01 | 0.537 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.495247e-01 | 0.603 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.230397e-01 | 0.491 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 1.735731e-01 | 0.761 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.914261e-01 | 0.718 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.647527e-01 | 0.577 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.201344e-01 | 0.657 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.065144e-01 | 0.685 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.108198e-01 | 0.386 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.048962e-01 | 0.516 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.114505e-01 | 0.675 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.074504e-01 | 0.683 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.074504e-01 | 0.683 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.545494e-01 | 0.811 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.780599e-01 | 0.422 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.533669e-01 | 0.452 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.009633e-01 | 0.521 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.099305e-01 | 0.678 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.420437e-01 | 0.355 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.132671e-01 | 0.671 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.871274e-01 | 0.728 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.917454e-01 | 0.535 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.901641e-01 | 0.537 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.816601e-01 | 0.550 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.162333e-01 | 0.665 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.195221e-01 | 0.495 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.909442e-01 | 0.408 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.055053e-01 | 0.687 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.723692e-01 | 0.764 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.398306e-01 | 0.620 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.153348e-01 | 0.501 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.407433e-01 | 0.468 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.048962e-01 | 0.516 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.695281e-01 | 0.569 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 4.161491e-01 | 0.381 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.407127e-01 | 0.356 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.371225e-01 | 0.472 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.793242e-01 | 0.421 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.369208e-01 | 0.360 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.172033e-01 | 0.380 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.721218e-01 | 0.764 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.628433e-01 | 0.440 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.441209e-01 | 0.612 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.853338e-01 | 0.414 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.509784e-01 | 0.455 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.055053e-01 | 0.687 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.292739e-01 | 0.482 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.647527e-01 | 0.577 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.068876e-01 | 0.391 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.516783e-01 | 0.345 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.533669e-01 | 0.452 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.875877e-01 | 0.727 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.448685e-01 | 0.611 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.305621e-01 | 0.366 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.305621e-01 | 0.366 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.397632e-01 | 0.357 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.609019e-01 | 0.443 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.510892e-01 | 0.455 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.614763e-01 | 0.583 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.659916e-01 | 0.437 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.199405e-01 | 0.658 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.908560e-01 | 0.719 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.398306e-01 | 0.620 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.660800e-01 | 0.436 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.953733e-01 | 0.403 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.162308e-01 | 0.381 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.243525e-01 | 0.649 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.794583e-01 | 0.421 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.499842e-01 | 0.602 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.773768e-01 | 0.751 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.633658e-01 | 0.787 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.108198e-01 | 0.386 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.905248e-01 | 0.537 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.912622e-01 | 0.536 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.912451e-01 | 0.408 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.277099e-01 | 0.485 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.694871e-01 | 0.771 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.647527e-01 | 0.577 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.074363e-01 | 0.512 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.137618e-01 | 0.503 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.385770e-01 | 0.358 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.453691e-01 | 0.610 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.453691e-01 | 0.610 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.129721e-01 | 0.504 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.129721e-01 | 0.504 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.415634e-01 | 0.617 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.745226e-01 | 0.427 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.760771e-01 | 0.559 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.723692e-01 | 0.764 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.305621e-01 | 0.366 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.647527e-01 | 0.577 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.647527e-01 | 0.577 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.698873e-01 | 0.569 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.780599e-01 | 0.422 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.780599e-01 | 0.422 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.427047e-01 | 0.354 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.427047e-01 | 0.354 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.744001e-01 | 0.427 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.508804e-01 | 0.346 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.450595e-01 | 0.352 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.219386e-01 | 0.654 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.894467e-01 | 0.723 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.048962e-01 | 0.516 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.976272e-01 | 0.526 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.881829e-01 | 0.540 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.488214e-01 | 0.348 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.522532e-01 | 0.817 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.945565e-01 | 0.404 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.899644e-01 | 0.538 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.533669e-01 | 0.452 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.568820e-01 | 0.804 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.914261e-01 | 0.718 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.048962e-01 | 0.516 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.912451e-01 | 0.408 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.285727e-01 | 0.483 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.953733e-01 | 0.403 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.407127e-01 | 0.356 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.069042e-01 | 0.684 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.099490e-01 | 0.678 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.445615e-01 | 0.463 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.162308e-01 | 0.381 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.416436e-01 | 0.617 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.946092e-01 | 0.531 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.733101e-01 | 0.428 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.415634e-01 | 0.617 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.104964e-01 | 0.508 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.780599e-01 | 0.422 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.564825e-01 | 0.591 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.445615e-01 | 0.463 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.573270e-01 | 0.803 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.398306e-01 | 0.620 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.621748e-01 | 0.441 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.387806e-01 | 0.470 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.793242e-01 | 0.421 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.793242e-01 | 0.421 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.909442e-01 | 0.408 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.732851e-01 | 0.761 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.132671e-01 | 0.671 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.458521e-01 | 0.609 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.552188e-01 | 0.809 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.201344e-01 | 0.657 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.958146e-01 | 0.403 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.131220e-01 | 0.504 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.432687e-01 | 0.464 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.988287e-01 | 0.399 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.453691e-01 | 0.610 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.735731e-01 | 0.761 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.104964e-01 | 0.508 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.305621e-01 | 0.366 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.445615e-01 | 0.463 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.899644e-01 | 0.538 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.201344e-01 | 0.657 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.350975e-01 | 0.629 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.958146e-01 | 0.403 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.779779e-01 | 0.423 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.694871e-01 | 0.771 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.814025e-01 | 0.741 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.501212e-01 | 0.602 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.445615e-01 | 0.463 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.161491e-01 | 0.381 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.616954e-01 | 0.582 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.488214e-01 | 0.348 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.609396e-01 | 0.793 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.300308e-01 | 0.481 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.912451e-01 | 0.408 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.445615e-01 | 0.463 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.048962e-01 | 0.516 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.879132e-01 | 0.541 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.547324e-01 | 0.342 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.547324e-01 | 0.342 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.547324e-01 | 0.342 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.547324e-01 | 0.342 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.463544e-01 | 0.460 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.901641e-01 | 0.537 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.660800e-01 | 0.436 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.547324e-01 | 0.342 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.415634e-01 | 0.617 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.415634e-01 | 0.617 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.760771e-01 | 0.559 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.760771e-01 | 0.559 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.104964e-01 | 0.508 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.305621e-01 | 0.366 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.108198e-01 | 0.386 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.247851e-01 | 0.648 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.328053e-01 | 0.364 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.201344e-01 | 0.657 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.303253e-01 | 0.366 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.295131e-01 | 0.639 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.427047e-01 | 0.354 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 3.963184e-01 | 0.402 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.631225e-01 | 0.787 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.912451e-01 | 0.408 | 0 | 0 |
| Depurination | R-HSA-73927 | 4.146065e-01 | 0.382 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.735731e-01 | 0.761 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.072698e-01 | 0.683 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.647527e-01 | 0.577 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.108198e-01 | 0.386 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.869121e-01 | 0.542 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.366841e-01 | 0.473 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.509784e-01 | 0.455 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.822471e-01 | 0.418 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.445615e-01 | 0.463 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.495247e-01 | 0.603 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.343880e-01 | 0.630 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.976272e-01 | 0.526 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.397632e-01 | 0.357 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.300308e-01 | 0.481 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.300308e-01 | 0.481 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.647527e-01 | 0.577 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.912424e-01 | 0.718 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.427047e-01 | 0.354 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.881574e-01 | 0.725 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.564825e-01 | 0.591 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.450704e-01 | 0.611 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.445615e-01 | 0.463 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.009633e-01 | 0.521 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.572743e-01 | 0.340 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.573958e-01 | 0.340 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.575475e-01 | 0.340 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.613107e-01 | 0.336 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.627086e-01 | 0.335 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.627239e-01 | 0.335 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 4.631212e-01 | 0.334 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.648657e-01 | 0.333 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.648657e-01 | 0.333 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.648657e-01 | 0.333 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.687992e-01 | 0.329 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.687992e-01 | 0.329 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.687992e-01 | 0.329 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.687992e-01 | 0.329 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 4.687992e-01 | 0.329 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.687992e-01 | 0.329 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.687992e-01 | 0.329 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.694935e-01 | 0.328 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.696186e-01 | 0.328 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.730326e-01 | 0.325 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.736087e-01 | 0.325 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.736087e-01 | 0.325 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.736087e-01 | 0.325 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.736087e-01 | 0.325 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.736087e-01 | 0.325 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.755729e-01 | 0.323 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.765238e-01 | 0.322 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.765238e-01 | 0.322 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.774391e-01 | 0.321 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.776122e-01 | 0.321 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.815838e-01 | 0.317 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.815838e-01 | 0.317 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.815838e-01 | 0.317 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.815838e-01 | 0.317 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.815838e-01 | 0.317 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.815838e-01 | 0.317 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.815838e-01 | 0.317 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.815838e-01 | 0.317 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.815838e-01 | 0.317 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.815838e-01 | 0.317 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.815838e-01 | 0.317 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.815838e-01 | 0.317 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.815838e-01 | 0.317 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.815838e-01 | 0.317 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.815838e-01 | 0.317 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.844034e-01 | 0.315 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.865315e-01 | 0.313 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.865315e-01 | 0.313 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.865315e-01 | 0.313 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.885474e-01 | 0.311 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.885474e-01 | 0.311 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.885474e-01 | 0.311 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.885474e-01 | 0.311 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.885474e-01 | 0.311 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.885474e-01 | 0.311 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.902523e-01 | 0.310 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.934221e-01 | 0.307 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.934221e-01 | 0.307 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.975307e-01 | 0.303 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.975307e-01 | 0.303 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.975307e-01 | 0.303 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.975307e-01 | 0.303 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 4.975307e-01 | 0.303 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.990691e-01 | 0.302 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.990691e-01 | 0.302 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.990691e-01 | 0.302 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.034514e-01 | 0.298 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.038798e-01 | 0.298 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.040494e-01 | 0.298 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.092387e-01 | 0.293 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.117054e-01 | 0.291 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.117054e-01 | 0.291 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.117054e-01 | 0.291 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.117054e-01 | 0.291 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.117054e-01 | 0.291 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.117054e-01 | 0.291 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 5.171158e-01 | 0.286 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.183943e-01 | 0.285 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.213271e-01 | 0.283 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.213271e-01 | 0.283 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.213271e-01 | 0.283 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.245715e-01 | 0.280 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.248690e-01 | 0.280 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.248690e-01 | 0.280 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.280367e-01 | 0.277 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.280367e-01 | 0.277 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.280367e-01 | 0.277 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.280367e-01 | 0.277 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.280367e-01 | 0.277 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.280367e-01 | 0.277 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.280367e-01 | 0.277 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.280367e-01 | 0.277 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.280367e-01 | 0.277 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.280367e-01 | 0.277 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.280367e-01 | 0.277 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.280367e-01 | 0.277 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.280367e-01 | 0.277 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.321751e-01 | 0.274 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.321751e-01 | 0.274 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.321751e-01 | 0.274 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.321751e-01 | 0.274 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.321751e-01 | 0.274 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.342954e-01 | 0.272 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 5.342954e-01 | 0.272 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.363361e-01 | 0.271 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.363361e-01 | 0.271 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.363361e-01 | 0.271 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.363361e-01 | 0.271 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.363361e-01 | 0.271 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.363361e-01 | 0.271 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.363361e-01 | 0.271 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.383410e-01 | 0.269 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.402948e-01 | 0.267 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.440238e-01 | 0.264 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.539330e-01 | 0.257 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.550699e-01 | 0.256 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 5.551636e-01 | 0.256 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 5.551636e-01 | 0.256 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.551636e-01 | 0.256 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.551636e-01 | 0.256 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.554991e-01 | 0.255 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.554991e-01 | 0.255 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.562217e-01 | 0.255 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.562807e-01 | 0.255 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.562807e-01 | 0.255 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.562807e-01 | 0.255 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.597407e-01 | 0.252 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.597407e-01 | 0.252 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.597407e-01 | 0.252 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.597407e-01 | 0.252 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.597407e-01 | 0.252 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.597407e-01 | 0.252 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.597407e-01 | 0.252 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.597407e-01 | 0.252 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.597407e-01 | 0.252 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.597407e-01 | 0.252 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.597407e-01 | 0.252 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.662272e-01 | 0.247 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.700510e-01 | 0.244 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.700611e-01 | 0.244 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.703297e-01 | 0.244 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.703297e-01 | 0.244 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.703297e-01 | 0.244 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.703297e-01 | 0.244 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.703297e-01 | 0.244 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.703297e-01 | 0.244 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.703297e-01 | 0.244 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.703297e-01 | 0.244 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.703297e-01 | 0.244 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.703297e-01 | 0.244 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.703297e-01 | 0.244 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.714945e-01 | 0.243 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.714945e-01 | 0.243 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.735743e-01 | 0.241 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.776312e-01 | 0.238 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.776312e-01 | 0.238 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.860790e-01 | 0.232 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.861251e-01 | 0.232 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.861251e-01 | 0.232 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.861251e-01 | 0.232 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.861251e-01 | 0.232 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.861251e-01 | 0.232 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.861251e-01 | 0.232 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.861251e-01 | 0.232 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.875978e-01 | 0.231 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.915473e-01 | 0.228 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.915473e-01 | 0.228 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.915473e-01 | 0.228 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.927156e-01 | 0.227 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.947876e-01 | 0.226 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.983233e-01 | 0.223 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.983233e-01 | 0.223 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.983233e-01 | 0.223 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.033648e-01 | 0.219 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.088351e-01 | 0.216 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.088351e-01 | 0.216 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.088351e-01 | 0.216 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.088351e-01 | 0.216 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.088351e-01 | 0.216 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.088351e-01 | 0.216 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.088351e-01 | 0.216 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.088351e-01 | 0.216 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.088351e-01 | 0.216 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.090651e-01 | 0.215 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.090651e-01 | 0.215 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.103097e-01 | 0.214 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.103097e-01 | 0.214 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.103097e-01 | 0.214 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.106130e-01 | 0.214 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.113186e-01 | 0.214 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.113186e-01 | 0.214 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.113186e-01 | 0.214 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.183395e-01 | 0.209 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.183395e-01 | 0.209 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.183395e-01 | 0.209 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.183395e-01 | 0.209 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.250194e-01 | 0.204 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.261134e-01 | 0.203 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.261134e-01 | 0.203 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.289354e-01 | 0.201 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.327995e-01 | 0.199 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.327995e-01 | 0.199 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.353227e-01 | 0.197 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.353227e-01 | 0.197 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.353227e-01 | 0.197 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.353227e-01 | 0.197 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.353227e-01 | 0.197 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.353227e-01 | 0.197 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.366154e-01 | 0.196 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.370892e-01 | 0.196 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.376670e-01 | 0.195 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.376670e-01 | 0.195 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.376670e-01 | 0.195 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.392433e-01 | 0.194 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.413040e-01 | 0.193 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.426805e-01 | 0.192 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.438918e-01 | 0.191 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.438918e-01 | 0.191 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.438918e-01 | 0.191 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.438918e-01 | 0.191 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.438918e-01 | 0.191 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.438918e-01 | 0.191 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.438918e-01 | 0.191 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.438918e-01 | 0.191 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.438918e-01 | 0.191 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.438918e-01 | 0.191 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.438918e-01 | 0.191 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.438918e-01 | 0.191 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 6.438918e-01 | 0.191 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.485256e-01 | 0.188 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.485256e-01 | 0.188 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.547296e-01 | 0.184 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.547296e-01 | 0.184 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.552958e-01 | 0.184 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.562981e-01 | 0.183 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.562981e-01 | 0.183 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.579393e-01 | 0.182 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.581484e-01 | 0.182 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.581484e-01 | 0.182 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.581484e-01 | 0.182 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.581484e-01 | 0.182 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.615648e-01 | 0.179 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.628344e-01 | 0.179 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.628344e-01 | 0.179 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.649910e-01 | 0.177 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.717100e-01 | 0.173 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.737205e-01 | 0.172 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.743385e-01 | 0.171 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.758086e-01 | 0.170 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.758086e-01 | 0.170 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.758086e-01 | 0.170 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.758086e-01 | 0.170 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.758086e-01 | 0.170 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.758086e-01 | 0.170 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.758086e-01 | 0.170 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.758086e-01 | 0.170 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.758086e-01 | 0.170 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.758086e-01 | 0.170 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.758086e-01 | 0.170 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.758086e-01 | 0.170 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.758086e-01 | 0.170 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.767593e-01 | 0.170 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.767593e-01 | 0.170 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.798139e-01 | 0.168 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.802640e-01 | 0.167 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.879015e-01 | 0.162 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.880541e-01 | 0.162 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.889110e-01 | 0.162 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.908302e-01 | 0.161 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.914610e-01 | 0.160 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.930554e-01 | 0.159 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.930554e-01 | 0.159 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.930554e-01 | 0.159 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.940323e-01 | 0.159 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.975253e-01 | 0.156 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.003438e-01 | 0.155 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.003438e-01 | 0.155 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.003438e-01 | 0.155 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.003438e-01 | 0.155 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.003438e-01 | 0.155 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.003438e-01 | 0.155 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.003438e-01 | 0.155 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.003438e-01 | 0.155 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.034401e-01 | 0.153 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.039974e-01 | 0.152 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.039974e-01 | 0.152 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.048665e-01 | 0.152 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.048665e-01 | 0.152 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.048665e-01 | 0.152 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.048665e-01 | 0.152 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.048665e-01 | 0.152 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.048665e-01 | 0.152 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.048665e-01 | 0.152 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.048665e-01 | 0.152 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.048665e-01 | 0.152 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.048665e-01 | 0.152 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.048665e-01 | 0.152 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.069630e-01 | 0.151 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.069630e-01 | 0.151 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.079967e-01 | 0.150 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.079967e-01 | 0.150 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.079967e-01 | 0.150 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.096761e-01 | 0.149 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.150265e-01 | 0.146 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.177432e-01 | 0.144 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.177432e-01 | 0.144 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.180736e-01 | 0.144 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.197676e-01 | 0.143 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.197676e-01 | 0.143 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.197676e-01 | 0.143 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.197676e-01 | 0.143 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.228261e-01 | 0.141 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.238430e-01 | 0.140 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.313215e-01 | 0.136 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.313215e-01 | 0.136 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.313215e-01 | 0.136 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.313215e-01 | 0.136 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.313215e-01 | 0.136 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.313215e-01 | 0.136 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.313215e-01 | 0.136 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.313215e-01 | 0.136 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.313215e-01 | 0.136 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.313215e-01 | 0.136 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.313215e-01 | 0.136 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.313215e-01 | 0.136 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.313215e-01 | 0.136 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.313215e-01 | 0.136 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.313215e-01 | 0.136 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.316494e-01 | 0.136 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.316494e-01 | 0.136 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.317721e-01 | 0.136 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.341398e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.341398e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.381187e-01 | 0.132 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.389998e-01 | 0.131 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.390092e-01 | 0.131 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.390092e-01 | 0.131 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 7.405119e-01 | 0.130 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.405119e-01 | 0.130 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.520837e-01 | 0.124 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.535066e-01 | 0.123 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.554065e-01 | 0.122 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.554065e-01 | 0.122 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.554065e-01 | 0.122 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.554065e-01 | 0.122 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.554065e-01 | 0.122 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.554065e-01 | 0.122 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.554065e-01 | 0.122 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.554065e-01 | 0.122 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.554332e-01 | 0.122 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.597775e-01 | 0.119 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.620508e-01 | 0.118 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.637997e-01 | 0.117 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.673486e-01 | 0.115 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.673486e-01 | 0.115 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.673486e-01 | 0.115 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.673486e-01 | 0.115 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.694170e-01 | 0.114 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.694170e-01 | 0.114 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.717494e-01 | 0.113 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.717494e-01 | 0.113 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.717494e-01 | 0.113 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.755544e-01 | 0.110 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.771585e-01 | 0.109 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.773338e-01 | 0.109 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.773338e-01 | 0.109 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.773338e-01 | 0.109 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.773338e-01 | 0.109 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.773338e-01 | 0.109 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.773338e-01 | 0.109 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.773338e-01 | 0.109 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.773338e-01 | 0.109 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.773338e-01 | 0.109 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.773338e-01 | 0.109 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.773338e-01 | 0.109 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.773338e-01 | 0.109 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.773338e-01 | 0.109 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.773338e-01 | 0.109 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 7.773338e-01 | 0.109 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 7.773338e-01 | 0.109 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.773338e-01 | 0.109 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.773338e-01 | 0.109 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.773338e-01 | 0.109 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.773338e-01 | 0.109 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.815312e-01 | 0.107 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.871071e-01 | 0.104 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.871071e-01 | 0.104 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.871071e-01 | 0.104 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.892938e-01 | 0.103 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.908078e-01 | 0.102 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.972966e-01 | 0.098 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 7.972966e-01 | 0.098 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.972966e-01 | 0.098 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.972966e-01 | 0.098 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.972966e-01 | 0.098 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.972966e-01 | 0.098 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.972966e-01 | 0.098 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.981325e-01 | 0.098 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.981325e-01 | 0.098 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.006105e-01 | 0.097 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.015471e-01 | 0.096 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.041880e-01 | 0.095 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.047316e-01 | 0.094 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.050977e-01 | 0.094 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.050977e-01 | 0.094 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.050977e-01 | 0.094 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.112975e-01 | 0.091 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.118709e-01 | 0.091 | 0 | 0 |
| Translation | R-HSA-72766 | 8.130417e-01 | 0.090 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.131265e-01 | 0.090 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.151103e-01 | 0.089 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.151103e-01 | 0.089 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.151103e-01 | 0.089 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.151103e-01 | 0.089 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.151103e-01 | 0.089 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.154706e-01 | 0.089 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.154706e-01 | 0.089 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.154706e-01 | 0.089 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.154706e-01 | 0.089 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.154706e-01 | 0.089 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.154706e-01 | 0.089 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.154706e-01 | 0.089 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.154706e-01 | 0.089 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.154706e-01 | 0.089 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.154706e-01 | 0.089 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.157964e-01 | 0.088 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.164794e-01 | 0.088 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.164794e-01 | 0.088 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.164794e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.189709e-01 | 0.087 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.189709e-01 | 0.087 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.231447e-01 | 0.085 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.232750e-01 | 0.084 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.278380e-01 | 0.082 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.320163e-01 | 0.080 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.320163e-01 | 0.080 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.320163e-01 | 0.080 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.320163e-01 | 0.080 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.320163e-01 | 0.080 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.320163e-01 | 0.080 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.320163e-01 | 0.080 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.320163e-01 | 0.080 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.320163e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.375526e-01 | 0.077 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.375526e-01 | 0.077 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.375526e-01 | 0.077 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.375526e-01 | 0.077 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.375526e-01 | 0.077 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.375526e-01 | 0.077 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.396007e-01 | 0.076 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.397707e-01 | 0.076 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.397707e-01 | 0.076 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.397707e-01 | 0.076 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.470792e-01 | 0.072 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.470792e-01 | 0.072 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.470792e-01 | 0.072 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.470792e-01 | 0.072 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.470792e-01 | 0.072 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.470792e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.498042e-01 | 0.071 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.509488e-01 | 0.070 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.509488e-01 | 0.070 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.527808e-01 | 0.069 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.540434e-01 | 0.069 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.565029e-01 | 0.067 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.571240e-01 | 0.067 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.607923e-01 | 0.065 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.607923e-01 | 0.065 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.607923e-01 | 0.065 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.607923e-01 | 0.065 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.607923e-01 | 0.065 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.607923e-01 | 0.065 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.614115e-01 | 0.065 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.642384e-01 | 0.063 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.652317e-01 | 0.063 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.689984e-01 | 0.061 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.707037e-01 | 0.060 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.732764e-01 | 0.059 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.732764e-01 | 0.059 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.732764e-01 | 0.059 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.732764e-01 | 0.059 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.732764e-01 | 0.059 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.732764e-01 | 0.059 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.732764e-01 | 0.059 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.732764e-01 | 0.059 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.732764e-01 | 0.059 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.734893e-01 | 0.059 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.734893e-01 | 0.059 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.737528e-01 | 0.059 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.803434e-01 | 0.055 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.803434e-01 | 0.055 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.803434e-01 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.812955e-01 | 0.055 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.812955e-01 | 0.055 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.812955e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.821058e-01 | 0.054 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.835414e-01 | 0.054 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.844072e-01 | 0.053 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.844072e-01 | 0.053 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.846417e-01 | 0.053 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.846417e-01 | 0.053 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.846417e-01 | 0.053 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.846417e-01 | 0.053 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.850538e-01 | 0.053 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.869039e-01 | 0.052 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.869039e-01 | 0.052 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.869039e-01 | 0.052 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.886699e-01 | 0.051 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.886699e-01 | 0.051 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.888857e-01 | 0.051 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.888857e-01 | 0.051 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.905799e-01 | 0.050 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.932823e-01 | 0.049 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.949882e-01 | 0.048 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.949882e-01 | 0.048 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 8.949882e-01 | 0.048 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.956314e-01 | 0.048 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.968590e-01 | 0.047 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.968590e-01 | 0.047 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.968590e-01 | 0.047 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.978137e-01 | 0.047 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.021990e-01 | 0.045 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.042965e-01 | 0.044 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.044073e-01 | 0.044 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.044073e-01 | 0.044 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.044073e-01 | 0.044 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.044073e-01 | 0.044 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.044073e-01 | 0.044 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.044073e-01 | 0.044 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.050975e-01 | 0.043 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.081142e-01 | 0.042 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.083911e-01 | 0.042 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.105589e-01 | 0.041 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.112303e-01 | 0.040 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.112303e-01 | 0.040 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.112303e-01 | 0.040 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.129821e-01 | 0.040 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.129821e-01 | 0.040 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.129821e-01 | 0.040 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.129821e-01 | 0.040 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.129821e-01 | 0.040 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.131453e-01 | 0.039 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.142254e-01 | 0.039 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.147684e-01 | 0.039 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.153148e-01 | 0.038 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.176577e-01 | 0.037 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.207882e-01 | 0.036 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.207882e-01 | 0.036 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.207882e-01 | 0.036 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.207882e-01 | 0.036 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.207882e-01 | 0.036 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.219858e-01 | 0.035 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.219858e-01 | 0.035 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.219858e-01 | 0.035 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.237071e-01 | 0.034 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.237071e-01 | 0.034 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.278937e-01 | 0.033 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.278944e-01 | 0.033 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.278944e-01 | 0.033 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.278944e-01 | 0.033 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.278944e-01 | 0.033 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.278944e-01 | 0.033 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.278944e-01 | 0.033 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.293069e-01 | 0.032 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.293069e-01 | 0.032 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.321730e-01 | 0.031 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.335934e-01 | 0.030 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.338750e-01 | 0.030 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.343265e-01 | 0.030 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.343635e-01 | 0.029 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.343635e-01 | 0.029 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.343635e-01 | 0.029 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.343635e-01 | 0.029 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.343635e-01 | 0.029 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.343635e-01 | 0.029 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.343635e-01 | 0.029 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.343635e-01 | 0.029 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.345165e-01 | 0.029 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.345165e-01 | 0.029 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.386229e-01 | 0.028 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.393607e-01 | 0.027 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.402526e-01 | 0.027 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.402526e-01 | 0.027 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.402526e-01 | 0.027 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.402526e-01 | 0.027 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.402526e-01 | 0.027 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.426580e-01 | 0.026 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.426580e-01 | 0.026 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.438632e-01 | 0.025 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.438632e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.438632e-01 | 0.025 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.446565e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.456136e-01 | 0.024 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.456136e-01 | 0.024 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.456136e-01 | 0.024 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.456136e-01 | 0.024 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.456136e-01 | 0.024 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.456136e-01 | 0.024 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.456136e-01 | 0.024 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.476610e-01 | 0.023 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.480463e-01 | 0.023 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.480463e-01 | 0.023 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.499997e-01 | 0.022 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.499997e-01 | 0.022 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.504938e-01 | 0.022 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.504938e-01 | 0.022 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.504938e-01 | 0.022 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.504938e-01 | 0.022 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.504938e-01 | 0.022 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.504938e-01 | 0.022 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.519311e-01 | 0.021 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.526338e-01 | 0.021 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.533326e-01 | 0.021 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.533326e-01 | 0.021 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.533326e-01 | 0.021 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.545187e-01 | 0.020 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.549364e-01 | 0.020 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.549364e-01 | 0.020 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.549364e-01 | 0.020 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.549364e-01 | 0.020 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.549364e-01 | 0.020 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.549364e-01 | 0.020 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.555373e-01 | 0.020 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.564570e-01 | 0.019 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.564668e-01 | 0.019 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.573631e-01 | 0.019 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.589806e-01 | 0.018 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.589806e-01 | 0.018 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.593846e-01 | 0.018 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.593846e-01 | 0.018 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.599423e-01 | 0.018 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.599423e-01 | 0.018 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.599423e-01 | 0.018 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.619879e-01 | 0.017 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.626620e-01 | 0.017 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.626620e-01 | 0.017 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.626620e-01 | 0.017 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.644626e-01 | 0.016 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.646937e-01 | 0.016 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.660133e-01 | 0.015 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.660133e-01 | 0.015 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.669233e-01 | 0.015 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.682243e-01 | 0.014 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.686025e-01 | 0.014 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.690639e-01 | 0.014 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.690639e-01 | 0.014 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.690639e-01 | 0.014 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.690639e-01 | 0.014 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.690639e-01 | 0.014 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.690639e-01 | 0.014 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.693438e-01 | 0.014 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.714456e-01 | 0.013 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.718409e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.722973e-01 | 0.012 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.734103e-01 | 0.012 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.745618e-01 | 0.011 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.758773e-01 | 0.011 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.763820e-01 | 0.010 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.766698e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.766698e-01 | 0.010 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.766698e-01 | 0.010 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.769615e-01 | 0.010 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.777257e-01 | 0.010 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.781994e-01 | 0.010 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.787644e-01 | 0.009 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.787644e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.806711e-01 | 0.008 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.816930e-01 | 0.008 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.824067e-01 | 0.008 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.839474e-01 | 0.007 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.839865e-01 | 0.007 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.839865e-01 | 0.007 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.839865e-01 | 0.007 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.839865e-01 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.847052e-01 | 0.007 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.854245e-01 | 0.006 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.860931e-01 | 0.006 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.861563e-01 | 0.006 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.865703e-01 | 0.006 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.870105e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.871395e-01 | 0.006 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.878700e-01 | 0.005 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.879250e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.880553e-01 | 0.005 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.890096e-01 | 0.005 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.890096e-01 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.891486e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.899968e-01 | 0.004 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.908954e-01 | 0.004 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.908954e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.914142e-01 | 0.004 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.914295e-01 | 0.004 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.914295e-01 | 0.004 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.919222e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.924577e-01 | 0.003 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.924577e-01 | 0.003 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.929819e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.930272e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.930954e-01 | 0.003 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.931354e-01 | 0.003 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.931354e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.939111e-01 | 0.003 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.945600e-01 | 0.002 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.948246e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.948246e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.949934e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.952897e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.953928e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.957130e-01 | 0.002 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.957609e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.960983e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.961458e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.961458e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.962463e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.964126e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.965836e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.966950e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.966950e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.967682e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.969150e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.972097e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.973787e-01 | 0.001 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.975638e-01 | 0.001 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.975638e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.977225e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.977828e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.979237e-01 | 0.001 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.979669e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.981636e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.983288e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.983288e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.983288e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.984790e-01 | 0.001 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.984790e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.984790e-01 | 0.001 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.987022e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.987403e-01 | 0.001 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.987403e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.988467e-01 | 0.001 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.988613e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.988915e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.989055e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.991360e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.991552e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.992137e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.992137e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.993399e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.994075e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.994075e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.995015e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.995093e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.995315e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.995535e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.996352e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.996617e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.997063e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.997225e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.997693e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998648e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.998703e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998801e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998875e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999304e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999390e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999416e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999578e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999588e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999651e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999655e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999740e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999782e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999811e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999812e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999821e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999839e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999839e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999888e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999957e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999962e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999972e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999983e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999984e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999990e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999995e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999995e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999996e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999997e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |